data_2mg9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mg9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -73.25 -29.62 62.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.4 m -63.06 -26.64 68.93 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.4 0.68 . . . . 0.0 111.223 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -62.03 -35.3 78.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.488 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.12 106.85 17.54 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.058 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 62.84 26.79 15.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.05 0.94 . . . . 0.0 112.256 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 58.56 32.16 21.84 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.514 1.126 . . . . 0.0 109.805 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.05 -1.48 40.29 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.156 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.46 5.1 69.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.41 141.26 38.46 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.066 0.46 . . . . 0.0 110.226 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -83.21 -10.2 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.545 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -134.1 -167.5 1.97 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.4 127.26 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.428 0.558 . . . . 0.0 111.614 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.33 149.16 25.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.25 110.35 11.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.14 124.3 27.22 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.24 0.543 . . . . 0.0 111.216 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.72 167.6 10.21 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -66.66 -46.32 76.09 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 tp -109.78 109.55 28.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.935 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.94 -145.33 25.76 Favored Glycine 0 C--O 1.257 1.56 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -159.25 175.06 13.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.18 147.24 39.83 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 123.537 0.523 . . . . 0.0 109.623 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -111.49 128.19 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.31 -1.126 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.587 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -73.83 -27.96 61.37 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.749 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.7 m -68.38 -21.16 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.74 -34.51 75.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.47 101.19 12.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.963 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 53.88 38.04 27.84 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.797 1.239 . . . . 0.0 113.474 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.4 t30 62.73 26.2 15.5 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.782 1.233 . . . . 0.0 110.144 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.07 3.71 53.1 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.267 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.72 80.35 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.14 137.56 33.47 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.4 p -85.4 -5.65 59.28 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.941 0.876 . . . . 0.0 110.07 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -129.18 -166.42 1.65 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.05 129.27 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -92.32 145.29 24.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -125.16 108.51 11.85 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.5 112.7 12.09 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.411 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.42 167.65 11.04 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -57.95 -50.69 72.51 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.983 0.802 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.22 132.31 63.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.47 -145.34 49.63 Favored Glycine 0 C--O 1.272 2.481 0 C-N-CA 120.496 -0.859 . . . . 0.0 110.974 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.54 172.27 7.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -141.78 163.97 31.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.9 m -110.11 135.31 51.11 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -61.16 -36.15 79.03 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.657 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.1 m -65.1 -27.39 68.72 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.13 -30.42 70.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.314 0.578 . . . . 0.0 111.235 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.5 102.89 14.75 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 61.34 27.32 16.99 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.383 0.673 . . . . 0.0 111.801 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.6 t30 58.61 34.2 23.67 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.598 1.159 . . . . 0.0 109.79 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.24 2.82 74.52 Favored Glycine 0 C--O 1.243 0.702 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.811 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 18.57 66.19 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -108.54 144.42 36.24 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.988 0.423 . . . . 0.0 110.835 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -90.4 -7.41 53.27 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.098 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -114.55 -166.69 1.13 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.841 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.1 119.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 122.888 0.475 . . . . 0.0 110.919 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -99.76 130.02 45.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.69 110.24 17.62 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 124.888 1.275 . . . . 0.0 107.584 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.43 118.44 21.31 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.925 0.393 . . . . 0.0 111.902 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.5 mt -101.64 166.42 10.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.87 -45.94 87.18 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.479 0.657 . . . . 0.0 110.185 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.93 108.39 25.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.54 -145.75 28.05 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.996 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -162.61 171.85 16.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.148 0.979 . . . . 0.0 108.383 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -135.06 127.22 29.94 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.7 m -109.45 127.67 54.58 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.132 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--N 1.299 -1.616 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 -178.055 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 . . . . . 0 CA--C 1.505 -0.756 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 30.4 mp0 -63.91 -31.82 73.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.709 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.07 -29.47 70.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.46 -29.4 70.69 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.086 0.47 . . . . 0.0 112.12 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.47 107.91 19.08 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 57.92 34.46 24.34 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.95 35.4 21.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.467 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 69.27 10.33 62.42 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.798 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.86 85.7 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.0 m -92.93 134.87 34.67 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -81.31 -23.92 37.52 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -100.07 -170.13 1.83 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.732 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.7 130.69 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.606 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.9 t -88.58 143.69 26.79 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -126.24 113.23 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.22 129.82 35.55 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.204 0.526 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.3 mt -107.99 163.92 12.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -68.63 -45.33 72.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -105.47 87.82 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.106 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.33 -138.37 13.82 Favored Glycine 0 C--O 1.259 1.665 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.246 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 36.6 p90 -170.03 177.07 4.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.6 159.99 36.07 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.63 137.2 42.81 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.311 -1.08 0 CA-C-O 120.731 0.3 . . . . 0.0 110.563 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.478 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 48.6 t-20 . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -65.39 -26.95 68.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.251 0.548 . . . . 0.0 111.275 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 71.0 m -72.11 -17.28 61.99 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.089 -176.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.478 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 51.4 mt -63.57 -35.83 81.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -106.89 118.35 36.46 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.72 17.68 10.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.808 1.243 . . . . 0.0 111.334 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.2 t30 57.65 37.41 27.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.321 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.77 -1.18 54.67 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.29 60.92 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.9 m -107.04 145.53 32.25 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.313 0.578 . . . . 0.0 111.107 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.38 -23.25 26.22 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -92.91 -171.72 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.396 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.64 130.87 26.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 122.525 0.33 . . . . 0.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.0 t -113.75 138.54 50.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -129.44 127.88 41.82 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.127 0.489 . . . . 0.0 110.031 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -74.83 131.43 40.76 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.122 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.457 HD23 ' OE2' ' A' ' 24' ' ' GLU . 87.7 mt -110.87 164.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -67.11 -36.27 81.57 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.683 0.754 . . . . 0.0 110.046 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.1 116.19 51.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -146.3 38.86 Favored Glycine 0 C--O 1.268 2.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.343 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -162.45 170.95 17.88 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' OE2' HD23 ' A' ' 19' ' ' LEU . 17.1 pt-20 -133.72 148.22 51.41 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -117.52 121.35 40.74 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.86 -175.181 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 121.542 0.687 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -67.46 -29.11 68.48 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 89.5 m -70.96 -24.4 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.47 -29.14 66.74 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.155 0.503 . . . . 0.0 111.649 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -89.99 108.95 20.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.644 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 58.34 25.95 13.43 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.829 0.852 . . . . 0.0 112.799 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 64.7 t30 61.59 35.43 17.26 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 122.375 1.083 . . . . 0.0 109.19 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.98 82.3 Favored Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 -1.58 88.78 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.03 145.03 24.95 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.292 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.18 -13.39 35.66 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.992 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -105.82 -168.52 1.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.15 119.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 122.544 0.338 . . . . 0.0 111.019 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 t -100.3 122.55 43.27 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -109.06 102.69 11.65 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.14 112.46 6.52 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.907 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.77 166.25 14.76 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.66 -54.05 50.9 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 120.492 1.496 . . . . 0.0 108.981 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tp -111.24 118.66 57.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.03 -160.51 35.21 Favored Glycine 0 C--O 1.272 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -161.22 164.3 30.5 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.71 144.32 48.85 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.9 m -130.79 123.74 29.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.583 0.706 . . . . 0.0 110.978 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--N 1.296 -1.752 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.924 -176.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.405 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 46.7 t-20 . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -70.54 -32.44 69.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.305 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.06 -22.7 64.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.988 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 31.8 mt -61.1 -29.02 69.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.174 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -110.82 114.54 27.96 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.46 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 60.26 26.91 16.4 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.0 0.92 . . . . 0.0 112.162 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.61 33.63 20.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.285 1.04 . . . . 0.0 109.155 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.54 -0.26 56.17 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.379 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 1.17 77.57 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.37 132.58 33.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -85.43 -16.52 39.46 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -97.35 -166.4 1.39 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.3 144.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 118.735 0.698 . . . . 0.0 109.881 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -105.91 134.67 48.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -117.11 109.26 16.73 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.95 105.23 12.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.504 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.1 mt -84.48 170.03 13.91 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -58.04 -55.75 30.88 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-N 119.571 1.078 . . . . 0.0 109.539 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HD11 ' A' ' 21' ' ' ILE . 2.6 pp -109.32 130.25 62.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.44 -149.98 51.01 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.676 -172.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -174.14 176.47 2.51 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.7 151.57 45.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -99.33 129.42 45.54 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 121.061 0.458 . . . . 0.0 110.193 -178.183 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 6' ' ' LEU . 6.2 t30 . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -55.28 -31.25 61.43 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.355 1.062 . . . . 0.0 112.047 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 3' ' ' ASN . 55.6 m -61.57 -26.58 68.05 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.017 0.927 . . . . 0.0 111.878 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 3' ' ' ASN . 42.1 mt -65.36 -25.75 67.72 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.093 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.93 96.77 7.48 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.6 37.06 28.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.305 1.042 . . . . 0.0 111.924 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 61.93 28.96 17.66 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.246 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.13 1.15 67.8 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.669 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.84 24.94 65.76 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.34 144.33 25.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -77.67 -26.33 50.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -120.34 -166.64 1.34 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.488 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.04 131.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.402 0.62 . . . . 0.0 111.993 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.28 145.92 25.6 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.214 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -125.82 124.07 40.13 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -81.65 128.51 34.02 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.321 0.581 . . . . 0.0 112.537 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.6 mt -112.22 162.12 15.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.15 -22.62 48.48 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.896 0.855 . . . . 0.0 109.45 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.97 38.02 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 122.639 1.209 . . . . 0.0 112.292 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.48 -131.15 6.25 Favored Glycine 0 C--N 1.271 -3.038 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.025 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.0 176.77 11.89 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.57 146.0 37.48 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.3 m -108.51 119.03 38.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.018 -176.047 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 . . . . . 0 C--O 1.244 0.764 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -68.68 -27.85 66.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.071 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.0 m -67.73 -26.55 66.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.809 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.38 -28.24 69.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.661 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.87 113.89 27.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.534 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.63 23.2 13.8 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.649 1.214 . . . . 0.0 110.224 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 8.5 t30 57.81 35.13 25.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.901 -1.499 . . . . 0.0 108.859 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 -12.96 30.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.308 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.77 6.98 59.14 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.3 m -95.63 126.31 40.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -74.11 -16.53 61.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 109.517 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -113.19 -166.25 1.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.64 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.52 130.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.06 0.457 . . . . 0.0 110.902 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.77 135.82 40.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.42 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 50.7 t30 -116.31 101.45 8.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.3 116.22 15.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.714 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.03 166.84 10.2 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.69 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.632 0.73 . . . . 0.0 110.069 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.47 134.36 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -148.45 50.56 Favored Glycine 0 C--O 1.269 2.327 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.285 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -175.64 166.34 3.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.8 pt-20 -132.29 151.79 51.68 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.49 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -100.09 124.36 45.38 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 121.137 0.494 . . . . 0.0 110.096 -178.127 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.634 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.9 t30 . . . . . 0 CA--C 1.508 -0.644 0 CA-C-O 121.302 0.572 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -73.21 -21.36 60.67 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.524 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 72.9 m -73.4 -23.05 60.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 3' ' ' ASN . 4.1 pp -69.53 -29.38 66.97 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.909 1.337 . . . . 0.0 110.328 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.436 ' N ' HD13 ' A' ' 6' ' ' LEU . 19.9 t70 -88.87 97.5 11.21 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.133 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.58 32.29 18.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.403 1.081 . . . . 0.0 113.192 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 11.2 t30 62.7 32.26 16.25 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 124.434 1.094 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.36 3.57 66.39 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.852 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 5.51 89.77 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.3 m -86.91 132.47 33.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -78.52 -18.52 54.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.459 0.647 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -106.97 -166.52 1.17 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.693 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -59.59 140.65 17.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 120.788 0.328 . . . . 0.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.37 140.59 41.44 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.99 102.28 6.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.63 136.66 56.61 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.388 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.65 167.05 13.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -55.54 -48.31 74.91 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.0 pt -114.2 129.66 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.28 -139.82 48.41 Favored Glycine 0 C--O 1.266 2.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.101 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -169.64 178.82 3.98 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -142.41 147.7 36.61 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.2 m -91.84 141.73 28.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.306 -1.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.65 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 . . . . . 0 CA--C 1.497 -1.077 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -68.06 -21.56 64.98 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.698 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 84.4 m -76.59 -27.69 55.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.5 mt -67.77 -28.74 67.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.642 0.734 . . . . 0.0 110.602 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.01 103.02 15.66 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.476 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.46 23.6 13.21 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 124.44 1.096 . . . . 0.0 111.027 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.0 t30 60.39 36.68 20.34 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.642 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 5.32 71.7 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.087 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.81 13.7 71.73 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 78.6 m -109.84 144.33 38.45 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.955 0.883 . . . . 0.0 112.442 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.1 m -86.05 -22.85 27.0 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.792 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.5 176.74 7.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.77 132.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.458 0.474 . . . . 0.0 110.4 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -104.15 126.23 51.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -102.02 115.32 30.3 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.66 104.1 11.83 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.884 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.41 160.55 28.66 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -54.14 50.53 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.8 pt -104.69 134.18 46.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -153.24 46.49 Favored Glycine 0 C--O 1.278 2.868 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -158.88 173.47 16.47 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -143.31 113.73 7.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.812 0.445 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.29 136.6 32.87 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.693 -0.629 . . . . 0.0 110.531 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.393 -176.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.646 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t-20 . . . . . 0 CA--C 1.513 -0.472 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 23.5 mp0 -50.78 -37.42 42.23 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.071 0.548 . . . . 0.0 112.368 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.92 -23.82 55.08 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.983 0.913 . . . . 0.0 113.253 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.646 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 56.4 mt -65.16 -38.28 90.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.442 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.7 102.74 14.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.681 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 58.93 34.08 23.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.048 0.939 . . . . 0.0 112.004 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.2 29.32 17.43 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 -6.88 55.34 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.292 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.04 6.56 56.88 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.7 m -90.28 138.85 31.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -90.11 -21.28 22.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.815 0.817 . . . . 0.0 109.051 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -103.18 -166.19 1.24 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.55 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.22 133.45 25.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.198 0.523 . . . . 0.0 111.256 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -93.44 142.7 27.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.34 105.1 8.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.13 122.92 30.83 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.026 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.0 mt -106.2 166.42 10.53 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.026 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -63.41 -40.41 97.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -109.71 126.38 66.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.15 -136.9 47.9 Favored Glycine 0 C--O 1.271 2.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.307 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.486 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 7.4 p90 -175.76 -178.53 1.08 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.19 164.65 38.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.5 m -108.5 130.12 55.27 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.66 -15.02 55.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.423 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 93.3 m -80.86 -23.91 38.75 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 7' ' ' ASP . 3.8 pp -73.22 -30.32 63.41 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 123.101 1.429 . . . . 0.0 109.706 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' N ' HD13 ' A' ' 6' ' ' LEU . 28.4 t70 -88.54 103.96 16.38 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.554 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.51 24.64 14.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.364 1.078 . . . . 0.0 110.691 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 5.6 t30 57.95 36.49 26.23 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.602 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 72.66 0.73 50.64 Favored Glycine 0 C--O 1.244 0.721 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.91 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.36 89.45 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.7 m -100.53 136.94 39.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.7 p -76.38 -14.67 60.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.045 0.538 . . . . 0.0 112.01 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -111.99 -166.86 1.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.063 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.13 128.69 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 0.0 111.846 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.3 t -111.3 132.06 54.67 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -124.23 112.25 16.81 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -68.64 129.7 40.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.635 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -112.39 164.55 13.13 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.676 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.7 -46.44 90.37 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.688 0.618 . . . . 0.0 110.145 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.481 ' O ' HD11 ' A' ' 21' ' ' ILE . 2.7 pp -110.29 123.14 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.63 -142.62 42.51 Favored Glycine 0 C--O 1.271 2.446 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.694 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -167.57 163.27 14.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.18 153.15 39.15 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -125.81 125.34 42.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.591 0.71 . . . . 0.0 109.962 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.299 -1.6 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.358 -177.195 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 13.4 mp0 -70.85 -37.01 73.09 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.865 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.7 m -67.96 -28.12 67.19 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 124.023 0.929 . . . . 0.0 112.223 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -23.16 61.84 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -99.07 89.19 4.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.764 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.98 44.38 28.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.368 1.067 . . . . 0.0 113.139 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 59.99 28.69 18.25 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.888 1.275 . . . . 0.0 110.679 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.32 0.44 53.14 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.034 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.69 84.89 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.9 m -85.65 136.45 33.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.5 t -77.27 -16.44 58.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.959 0.409 . . . . 0.0 110.487 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -123.38 -164.37 1.21 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.734 0.814 . . . . 0.0 108.852 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.3 136.54 17.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 110.12 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.3 t -102.9 145.61 29.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -129.34 104.54 7.56 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.76 118.54 22.38 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.32 166.22 10.57 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.18 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.47 -32.51 48.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.282 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.6 tp -101.34 84.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.79 -132.77 11.49 Favored Glycine 0 C--O 1.253 1.3 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.631 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.509 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 22.9 p90 -156.79 177.98 10.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 136.24 21.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 123.068 0.547 . . . . 0.0 110.158 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.88 128.22 48.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 121.345 0.593 . . . . 0.0 109.946 -179.163 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.41 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 56.2 t-20 . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.34 -23.96 34.81 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.225 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 82.5 m -81.58 -19.31 42.22 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.721 0.772 . . . . 0.0 111.061 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 5.0 tt -62.26 -41.67 98.65 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.58 106.89 18.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.407 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 61.26 24.5 14.6 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.278 1.031 . . . . 0.0 112.71 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 65.7 t30 56.04 32.58 20.24 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.86 1.264 . . . . 0.0 109.73 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.12 -4.08 19.27 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.251 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.34 19.2 42.73 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.9 m -102.74 135.0 45.21 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -88.58 -14.48 37.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.683 0.754 . . . . 0.0 110.174 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -107.98 -166.67 1.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.64 137.88 23.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -107.33 144.91 33.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 42.3 t30 -118.17 113.9 22.24 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.43 94.26 4.87 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.662 0.744 . . . . 0.0 111.128 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 58.3 mt -71.07 165.49 23.4 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.22 -53.89 48.74 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.3 tp -96.02 113.75 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.331 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.71 -139.67 30.48 Favored Glycine 0 C--O 1.266 2.126 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.392 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 41.7 p90 -167.69 -176.43 3.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.3 pt-20 -147.31 142.16 26.85 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -89.06 123.87 33.76 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 121.341 0.591 . . . . 0.0 109.523 -177.605 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.25 -32.98 38.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.957 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.1 m -75.06 -21.59 58.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.31 -16.7 34.32 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 121.366 0.603 . . . . 0.0 111.048 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -98.16 92.53 5.79 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.144 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.3 26.6 12.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.97 1.367 . . . . 0.0 110.396 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.7 t30 57.6 37.51 27.53 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.822 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.8 7.02 60.89 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 13.16 82.28 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.9 m -106.43 148.94 27.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.127 0.489 . . . . 0.0 111.601 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.59 -19.23 23.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.595 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -92.37 -172.17 3.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.921 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.9 125.76 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.7 t -98.7 143.16 29.37 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.83 105.65 10.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.54 114.85 17.82 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.96 0.41 . . . . 0.0 111.602 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.23 165.78 12.64 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -72.13 -39.63 68.67 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 tp -117.65 87.5 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.379 1.085 . . . . 0.0 108.933 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.56 -148.55 17.09 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.63 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.9 p90 176.02 165.94 0.4 Allowed 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.93 168.68 19.68 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -119.95 128.89 54.0 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.513 -175.389 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.604 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 58.5 t-20 . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -69.22 -26.64 64.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 111.854 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 87.5 m -82.88 -17.35 44.11 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.592 0.71 . . . . 0.0 111.434 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.604 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 13.2 tp -71.29 -21.43 62.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -109.69 110.79 21.94 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.192 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 61.18 25.62 15.6 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.251 1.021 . . . . 0.0 113.129 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.1 t30 54.94 34.31 21.99 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.882 1.273 . . . . 0.0 109.92 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 7.38 67.07 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.604 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 4.44 78.89 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.7 m -105.62 148.56 27.2 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -90.39 -20.65 22.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.386 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.91 -167.17 1.55 Allowed 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.079 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.43 113.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.344 0.593 . . . . 0.0 110.439 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.9 t -92.09 135.8 33.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -117.06 112.69 21.26 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.141 0.496 . . . . 0.0 110.168 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.15 110.46 6.63 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.631 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -85.67 178.87 7.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.51 -55.0 13.22 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.44 112.37 39.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.77 -166.3 27.56 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.02 -173.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.44 168.21 22.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -135.54 161.15 36.3 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -124.43 129.27 50.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.058 -178.006 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.61 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.6 t-20 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -54.46 -33.23 59.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 56.7 m -63.14 -21.79 66.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.548 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.61 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 44.1 mt -64.0 -34.86 78.97 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.05 98.28 9.93 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 34.81 22.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.295 1.038 . . . . 0.0 112.352 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.5 t30 57.76 37.04 27.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 0.0 109.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.18 84.32 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.68 65.65 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.67 135.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.092 0.472 . . . . 0.0 111.119 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 m -89.15 -10.38 47.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.3 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -108.95 -168.16 1.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.96 117.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.165 0.507 . . . . 0.0 111.313 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -84.18 139.18 32.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -125.8 92.06 3.52 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.754 0.788 . . . . 0.0 108.976 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.19 119.83 19.85 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.56 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.05 170.0 8.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.92 -43.56 87.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 118.677 0.671 . . . . 0.0 109.425 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.55 110.11 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.81 -138.51 35.37 Favored Glycine 0 C--O 1.263 1.967 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.483 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -173.83 -176.74 1.26 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.91 169.96 23.6 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -131.29 149.48 52.54 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.52 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.668 -175.049 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.575 ' ND2' HD22 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -53.89 -38.52 64.88 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.931 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 79.0 m -61.01 -21.77 63.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.575 HD22 ' ND2' ' A' ' 3' ' ' ASN . 2.9 mm? -81.86 -17.35 47.65 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.94 107.05 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.818 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 60.35 28.95 18.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.821 0.819 . . . . 0.0 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 6.3 t30 53.27 41.19 32.14 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.823 1.649 . . . . 0.0 110.801 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.8 80.03 Favored Glycine 0 CA--C 1.504 -0.639 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.346 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.23 70.45 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.5 m -117.36 129.82 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -75.81 -29.15 58.59 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.863 0.363 . . . . 0.0 110.212 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -85.19 -171.15 3.48 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.413 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -56.86 134.68 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 123.586 0.554 . . . . 0.0 111.838 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.41 148.72 35.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -130.75 102.98 6.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.83 118.96 19.18 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.549 0.69 . . . . 0.0 112.143 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.36 166.55 10.36 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -67.37 -47.61 69.86 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.12 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.93 -141.58 31.91 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.137 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.34 178.75 9.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.23 151.25 40.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.4 m -126.67 134.06 50.8 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.274 -173.409 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.447 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.45 -37.56 56.76 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.597 0.759 . . . . 0.0 110.175 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.8 m -58.4 -25.69 62.4 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 63.6 mt -58.79 -39.25 80.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.41 125.32 53.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.748 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.35 19.46 11.7 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.572 1.149 . . . . 0.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.2 t30 58.4 33.05 22.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.156 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.31 6.61 61.87 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.343 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.93 78.78 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.8 m -85.4 128.75 34.82 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -79.41 -21.94 44.93 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.512 0.672 . . . . 0.0 109.31 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -103.79 -167.48 1.38 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.928 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.75 131.24 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 t -98.02 137.6 36.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -124.92 114.69 19.51 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.13 133.68 34.73 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.69 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.93 166.25 12.19 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -55.41 -49.43 72.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.801 0.81 . . . . 0.0 109.368 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.88 131.41 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.79 -138.41 41.76 Favored Glycine 0 C--O 1.263 1.962 0 O-C-N 123.742 0.651 . . . . 0.0 112.671 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -175.23 176.64 2.02 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.39 138.52 27.82 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.983 0.42 . . . . 0.0 110.796 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.07 125.43 35.86 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.606 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.368 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 t -163.13 140.54 7.69 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -93.9 109.88 21.57 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.571 0.224 . . . . 0.0 110.735 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -73.25 -29.62 62.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.4 m -63.06 -26.64 68.93 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.4 0.68 . . . . 0.0 111.223 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -62.03 -35.3 78.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.488 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.12 106.85 17.54 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.058 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 62.84 26.79 15.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.05 0.94 . . . . 0.0 112.256 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 58.56 32.16 21.84 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.514 1.126 . . . . 0.0 109.805 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.05 -1.48 40.29 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.156 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.46 5.1 69.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.41 141.26 38.46 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.066 0.46 . . . . 0.0 110.226 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -83.21 -10.2 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.545 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -134.1 -167.5 1.97 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.4 127.26 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.428 0.558 . . . . 0.0 111.614 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.33 149.16 25.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.25 110.35 11.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.14 124.3 27.22 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.24 0.543 . . . . 0.0 111.216 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.72 167.6 10.21 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -66.66 -46.32 76.09 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 tp -109.78 109.55 28.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.935 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.94 -145.33 25.76 Favored Glycine 0 C--O 1.257 1.56 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -159.25 175.06 13.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.18 147.24 39.83 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 123.537 0.523 . . . . 0.0 109.623 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -111.49 128.19 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.94 -99.88 0.43 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.998 0 O-C-N 122.022 -0.424 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.879 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 t -116.97 96.9 5.67 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.986 0.898 . . . . 0.0 112.043 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -95.61 108.55 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -73.83 -27.96 61.37 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.749 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.7 m -68.38 -21.16 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.74 -34.51 75.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.47 101.19 12.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.963 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 53.88 38.04 27.84 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.797 1.239 . . . . 0.0 113.474 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.4 t30 62.73 26.2 15.5 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.782 1.233 . . . . 0.0 110.144 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.07 3.71 53.1 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.267 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.72 80.35 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.14 137.56 33.47 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.4 p -85.4 -5.65 59.28 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.941 0.876 . . . . 0.0 110.07 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -129.18 -166.42 1.65 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.05 129.27 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -92.32 145.29 24.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -125.16 108.51 11.85 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.5 112.7 12.09 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.411 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.5 mt -96.42 167.65 11.04 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -57.95 -50.69 72.51 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.983 0.802 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.22 132.31 63.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.47 -145.34 49.63 Favored Glycine 0 C--O 1.272 2.481 0 C-N-CA 120.496 -0.859 . . . . 0.0 110.974 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.54 172.27 7.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -141.78 163.97 31.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.9 m -110.11 135.31 51.11 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -116.47 -90.59 0.55 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.143 0 O-C-N 122.3 -0.25 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -94.22 140.91 29.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -99.09 89.88 4.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -61.16 -36.15 79.03 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.657 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.1 m -65.1 -27.39 68.72 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.13 -30.42 70.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.314 0.578 . . . . 0.0 111.235 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.5 102.89 14.75 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 61.34 27.32 16.99 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.383 0.673 . . . . 0.0 111.801 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.6 t30 58.61 34.2 23.67 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.598 1.159 . . . . 0.0 109.79 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.24 2.82 74.52 Favored Glycine 0 C--O 1.243 0.702 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.811 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 18.57 66.19 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -108.54 144.42 36.24 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.988 0.423 . . . . 0.0 110.835 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -90.4 -7.41 53.27 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.098 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -114.55 -166.69 1.13 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.841 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.1 119.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 122.888 0.475 . . . . 0.0 110.919 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -99.76 130.02 45.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.69 110.24 17.62 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 124.888 1.275 . . . . 0.0 107.584 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.43 118.44 21.31 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.925 0.393 . . . . 0.0 111.902 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.5 mt -101.64 166.42 10.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.87 -45.94 87.18 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.479 0.657 . . . . 0.0 110.185 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.93 108.39 25.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.54 -145.75 28.05 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.996 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -162.61 171.85 16.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.148 0.979 . . . . 0.0 108.383 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -135.06 127.22 29.94 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.7 m -109.45 127.67 54.58 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.132 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.52 96.9 6.92 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 -178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 116.56 -0.291 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.462 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.1 m -65.77 136.82 56.73 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.327 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -104.19 95.96 6.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.404 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 30.4 mp0 -63.91 -31.82 73.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.709 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.07 -29.47 70.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.46 -29.4 70.69 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.086 0.47 . . . . 0.0 112.12 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.47 107.91 19.08 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 57.92 34.46 24.34 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.95 35.4 21.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.467 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 69.27 10.33 62.42 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.798 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.86 85.7 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.0 m -92.93 134.87 34.67 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -81.31 -23.92 37.52 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -100.07 -170.13 1.83 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.732 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.7 130.69 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.606 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.9 t -88.58 143.69 26.79 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -126.24 113.23 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.22 129.82 35.55 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.204 0.526 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.3 mt -107.99 163.92 12.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -68.63 -45.33 72.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -105.47 87.82 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.106 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.33 -138.37 13.82 Favored Glycine 0 C--O 1.259 1.665 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.246 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 36.6 p90 -170.03 177.07 4.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.6 159.99 36.07 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.63 137.2 42.81 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -119.17 -89.63 0.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.731 0.3 . . . . 0.0 110.563 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.035 0 O-C-N 122.185 -0.322 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.5 m -94.25 121.72 36.04 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 48.6 t-20 -94.62 98.15 10.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -65.39 -26.95 68.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.251 0.548 . . . . 0.0 111.275 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 71.0 m -72.11 -17.28 61.99 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.089 -176.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.478 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 51.4 mt -63.57 -35.83 81.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -106.89 118.35 36.46 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.72 17.68 10.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.808 1.243 . . . . 0.0 111.334 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.2 t30 57.65 37.41 27.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.321 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.77 -1.18 54.67 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.29 60.92 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.9 m -107.04 145.53 32.25 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.313 0.578 . . . . 0.0 111.107 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.38 -23.25 26.22 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -92.91 -171.72 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.396 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.64 130.87 26.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 122.525 0.33 . . . . 0.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.0 t -113.75 138.54 50.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -129.44 127.88 41.82 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.127 0.489 . . . . 0.0 110.031 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -74.83 131.43 40.76 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.122 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.457 HD23 ' OE2' ' A' ' 24' ' ' GLU . 87.7 mt -110.87 164.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -67.11 -36.27 81.57 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.683 0.754 . . . . 0.0 110.046 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.1 116.19 51.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -146.3 38.86 Favored Glycine 0 C--O 1.268 2.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.343 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -162.45 170.95 17.88 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' OE2' HD23 ' A' ' 19' ' ' LEU . 17.1 pt-20 -133.72 148.22 51.41 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -117.52 121.35 40.74 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.71 92.86 7.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.86 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 116.392 -0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.92 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -89.44 82.8 6.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -108.73 93.87 4.75 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.542 0.687 . . . . 0.0 109.945 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -67.46 -29.11 68.48 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 89.5 m -70.96 -24.4 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.47 -29.14 66.74 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.155 0.503 . . . . 0.0 111.649 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -89.99 108.95 20.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.644 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 58.34 25.95 13.43 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.829 0.852 . . . . 0.0 112.799 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 64.7 t30 61.59 35.43 17.26 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 122.375 1.083 . . . . 0.0 109.19 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 75.48 6.98 82.3 Favored Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 -1.58 88.78 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.03 145.03 24.95 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.292 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.18 -13.39 35.66 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.992 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -105.82 -168.52 1.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.15 119.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 122.544 0.338 . . . . 0.0 111.019 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 t -100.3 122.55 43.27 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -109.06 102.69 11.65 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.14 112.46 6.52 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.907 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.77 166.25 14.76 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.66 -54.05 50.9 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 120.492 1.496 . . . . 0.0 108.981 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tp -111.24 118.66 57.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.03 -160.51 35.21 Favored Glycine 0 C--O 1.272 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -161.22 164.3 30.5 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.71 144.32 48.85 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.9 m -130.79 123.74 29.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.583 0.706 . . . . 0.0 110.978 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.68 97.95 6.58 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.924 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 CA-C-N 116.556 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.756 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -88.21 107.07 18.6 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.479 0.657 . . . . 0.0 111.272 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.405 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 46.7 t-20 -107.22 102.35 11.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -70.54 -32.44 69.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.305 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.06 -22.7 64.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.988 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 31.8 mt -61.1 -29.02 69.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.174 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -110.82 114.54 27.96 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.46 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 60.26 26.91 16.4 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.0 0.92 . . . . 0.0 112.162 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.61 33.63 20.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.285 1.04 . . . . 0.0 109.155 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.54 -0.26 56.17 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.379 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 1.17 77.57 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.37 132.58 33.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -85.43 -16.52 39.46 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -97.35 -166.4 1.39 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.3 144.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 118.735 0.698 . . . . 0.0 109.881 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -105.91 134.67 48.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -117.11 109.26 16.73 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.95 105.23 12.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.504 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.1 mt -84.48 170.03 13.91 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -58.04 -55.75 30.88 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-N 119.571 1.078 . . . . 0.0 109.539 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' O ' HD11 ' A' ' 21' ' ' ILE . 2.6 pp -109.32 130.25 62.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.44 -149.98 51.01 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.676 -172.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -174.14 176.47 2.51 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.7 151.57 45.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -99.33 129.42 45.54 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.5 mt -107.06 96.15 6.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.061 0.458 . . . . 0.0 110.193 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.209 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t -59.37 121.68 12.05 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.994 0.902 . . . . 0.0 109.764 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 6' ' ' LEU . 6.2 t30 -103.29 95.12 5.89 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.227 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -55.28 -31.25 61.43 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.355 1.062 . . . . 0.0 112.047 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 3' ' ' ASN . 55.6 m -61.57 -26.58 68.05 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.017 0.927 . . . . 0.0 111.878 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 3' ' ' ASN . 42.1 mt -65.36 -25.75 67.72 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.093 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.93 96.77 7.48 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.6 37.06 28.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.305 1.042 . . . . 0.0 111.924 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 61.93 28.96 17.66 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.246 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.13 1.15 67.8 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.669 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.84 24.94 65.76 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.34 144.33 25.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -77.67 -26.33 50.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -120.34 -166.64 1.34 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.488 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.04 131.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.402 0.62 . . . . 0.0 111.993 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.28 145.92 25.6 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.214 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -125.82 124.07 40.13 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -81.65 128.51 34.02 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.321 0.581 . . . . 0.0 112.537 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.6 mt -112.22 162.12 15.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.15 -22.62 48.48 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.896 0.855 . . . . 0.0 109.45 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.97 38.02 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 122.639 1.209 . . . . 0.0 112.292 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.48 -131.15 6.25 Favored Glycine 0 C--N 1.271 -3.038 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.025 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.0 176.77 11.89 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.57 146.0 37.48 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.3 m -108.51 119.03 38.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.54 79.52 6.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.018 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.557 0 CA-C-N 116.053 -0.521 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 t -84.87 109.87 18.43 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.161 0.981 . . . . 0.0 112.69 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -100.34 100.61 11.43 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -68.68 -27.85 66.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.071 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.0 m -67.73 -26.55 66.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.809 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.38 -28.24 69.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.661 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.87 113.89 27.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.534 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.63 23.2 13.8 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.649 1.214 . . . . 0.0 110.224 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 8.5 t30 57.81 35.13 25.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.901 -1.499 . . . . 0.0 108.859 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 -12.96 30.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.308 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.77 6.98 59.14 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.3 m -95.63 126.31 40.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -74.11 -16.53 61.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 109.517 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -113.19 -166.25 1.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.64 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.52 130.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.06 0.457 . . . . 0.0 110.902 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.77 135.82 40.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.42 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 50.7 t30 -116.31 101.45 8.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.3 116.22 15.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.714 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.03 166.84 10.2 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.69 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.632 0.73 . . . . 0.0 110.069 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.47 134.36 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -148.45 50.56 Favored Glycine 0 C--O 1.269 2.327 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.285 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -175.64 166.34 3.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.8 pt-20 -132.29 151.79 51.68 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.49 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -100.09 124.36 45.38 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.6 93.06 8.76 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.137 0.494 . . . . 0.0 110.096 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.461 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -79.97 89.29 5.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.634 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.9 t30 -90.97 107.79 19.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.302 0.572 . . . . 0.0 110.782 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -73.21 -21.36 60.67 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.524 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 72.9 m -73.4 -23.05 60.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 3' ' ' ASN . 4.1 pp -69.53 -29.38 66.97 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.909 1.337 . . . . 0.0 110.328 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.436 ' N ' HD13 ' A' ' 6' ' ' LEU . 19.9 t70 -88.87 97.5 11.21 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.133 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.58 32.29 18.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.403 1.081 . . . . 0.0 113.192 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 11.2 t30 62.7 32.26 16.25 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 124.434 1.094 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.36 3.57 66.39 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.852 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 5.51 89.77 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.3 m -86.91 132.47 33.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -78.52 -18.52 54.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.459 0.647 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -106.97 -166.52 1.17 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.693 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.5 t -59.59 140.65 17.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 120.788 0.328 . . . . 0.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.37 140.59 41.44 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.99 102.28 6.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.63 136.66 56.61 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.388 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.65 167.05 13.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -55.54 -48.31 74.91 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.0 pt -114.2 129.66 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.28 -139.82 48.41 Favored Glycine 0 C--O 1.266 2.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.101 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -169.64 178.82 3.98 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -142.41 147.7 36.61 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.2 m -91.84 141.73 28.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -110.75 96.42 6.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.316 0 CA-C-N 116.607 -0.27 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.179 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 2' ' ' THR . 19.3 m -106.56 28.72 7.56 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.009 1.385 . . . . 0.0 111.551 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -112.65 87.87 2.69 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -68.06 -21.56 64.98 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.698 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 84.4 m -76.59 -27.69 55.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.5 mt -67.77 -28.74 67.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.642 0.734 . . . . 0.0 110.602 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.01 103.02 15.66 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.476 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.46 23.6 13.21 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 124.44 1.096 . . . . 0.0 111.027 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.0 t30 60.39 36.68 20.34 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.642 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 5.32 71.7 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.087 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.81 13.7 71.73 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 78.6 m -109.84 144.33 38.45 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.955 0.883 . . . . 0.0 112.442 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.1 m -86.05 -22.85 27.0 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.792 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.5 176.74 7.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.77 132.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.458 0.474 . . . . 0.0 110.4 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -104.15 126.23 51.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -102.02 115.32 30.3 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.66 104.1 11.83 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.884 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.41 160.55 28.66 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -54.14 50.53 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.8 pt -104.69 134.18 46.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -153.24 46.49 Favored Glycine 0 C--O 1.278 2.868 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -158.88 173.47 16.47 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -143.31 113.73 7.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.812 0.445 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.29 136.6 32.87 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.693 -0.629 . . . . 0.0 110.531 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.41 -93.55 0.52 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.393 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.816 0 O-C-N 122.067 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.721 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 m -82.65 115.62 21.68 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.646 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t-20 -98.36 82.33 2.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 23.5 mp0 -50.78 -37.42 42.23 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.071 0.548 . . . . 0.0 112.368 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.92 -23.82 55.08 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.983 0.913 . . . . 0.0 113.253 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.646 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 56.4 mt -65.16 -38.28 90.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.442 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.7 102.74 14.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.681 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 58.93 34.08 23.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.048 0.939 . . . . 0.0 112.004 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.2 29.32 17.43 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 -6.88 55.34 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.292 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.04 6.56 56.88 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.7 m -90.28 138.85 31.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -90.11 -21.28 22.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.815 0.817 . . . . 0.0 109.051 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -103.18 -166.19 1.24 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.55 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.22 133.45 25.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.198 0.523 . . . . 0.0 111.256 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -93.44 142.7 27.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.34 105.1 8.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.13 122.92 30.83 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.026 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.0 mt -106.2 166.42 10.53 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.026 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -63.41 -40.41 97.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -109.71 126.38 66.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.15 -136.9 47.9 Favored Glycine 0 C--O 1.271 2.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.307 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.486 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 7.4 p90 -175.76 -178.53 1.08 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.19 164.65 38.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.5 m -108.5 130.12 55.27 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.71 93.54 4.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.725 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.8 m -77.45 130.55 37.18 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 122.87 0.468 . . . . 0.0 110.008 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.51 99.59 12.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.66 -15.02 55.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.423 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 93.3 m -80.86 -23.91 38.75 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 7' ' ' ASP . 3.8 pp -73.22 -30.32 63.41 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 123.101 1.429 . . . . 0.0 109.706 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' N ' HD13 ' A' ' 6' ' ' LEU . 28.4 t70 -88.54 103.96 16.38 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.554 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.51 24.64 14.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.364 1.078 . . . . 0.0 110.691 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 5.6 t30 57.95 36.49 26.23 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.602 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 72.66 0.73 50.64 Favored Glycine 0 C--O 1.244 0.721 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.91 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.36 89.45 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.7 m -100.53 136.94 39.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.7 p -76.38 -14.67 60.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.045 0.538 . . . . 0.0 112.01 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -111.99 -166.86 1.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.063 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.13 128.69 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 0.0 111.846 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.3 t -111.3 132.06 54.67 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -124.23 112.25 16.81 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -68.64 129.7 40.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.635 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -112.39 164.55 13.13 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.676 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.7 -46.44 90.37 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.688 0.618 . . . . 0.0 110.145 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.481 ' O ' HD11 ' A' ' 21' ' ' ILE . 2.7 pp -110.29 123.14 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.63 -142.62 42.51 Favored Glycine 0 C--O 1.271 2.446 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.694 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -167.57 163.27 14.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.18 153.15 39.15 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -125.81 125.34 42.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.591 0.71 . . . . 0.0 109.962 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.56 87.72 2.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.358 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.613 0 CA-C-N 116.066 -0.515 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.385 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.4 m -78.59 88.81 4.51 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.811 0.815 . . . . 0.0 108.803 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -89.26 109.97 20.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.226 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.509 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 13.4 mp0 -70.85 -37.01 73.09 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.865 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.7 m -67.96 -28.12 67.19 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 124.023 0.929 . . . . 0.0 112.223 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -23.16 61.84 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -99.07 89.19 4.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.764 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.98 44.38 28.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.368 1.067 . . . . 0.0 113.139 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 59.99 28.69 18.25 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.888 1.275 . . . . 0.0 110.679 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.32 0.44 53.14 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.034 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.69 84.89 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.9 m -85.65 136.45 33.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.5 t -77.27 -16.44 58.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.959 0.409 . . . . 0.0 110.487 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -123.38 -164.37 1.21 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.734 0.814 . . . . 0.0 108.852 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.3 136.54 17.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 110.12 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.3 t -102.9 145.61 29.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -129.34 104.54 7.56 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.76 118.54 22.38 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.32 166.22 10.57 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.18 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.47 -32.51 48.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.282 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.6 tp -101.34 84.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.79 -132.77 11.49 Favored Glycine 0 C--O 1.253 1.3 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.631 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.509 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 22.9 p90 -156.79 177.98 10.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 136.24 21.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 123.068 0.547 . . . . 0.0 110.158 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.88 128.22 48.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.2 mt -103.06 77.68 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.345 0.593 . . . . 0.0 109.946 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 116.132 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.391 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -81.99 89.77 6.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.693 1.235 . . . . 0.0 109.256 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.41 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 56.2 t-20 -87.33 110.41 20.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.632 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.34 -23.96 34.81 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.225 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 82.5 m -81.58 -19.31 42.22 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.721 0.772 . . . . 0.0 111.061 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 5.0 tt -62.26 -41.67 98.65 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.58 106.89 18.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.407 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 61.26 24.5 14.6 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.278 1.031 . . . . 0.0 112.71 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.682 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 65.7 t30 56.04 32.58 20.24 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.86 1.264 . . . . 0.0 109.73 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.12 -4.08 19.27 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.251 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.34 19.2 42.73 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.9 m -102.74 135.0 45.21 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -88.58 -14.48 37.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.683 0.754 . . . . 0.0 110.174 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -107.98 -166.67 1.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.64 137.88 23.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -107.33 144.91 33.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 42.3 t30 -118.17 113.9 22.24 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.43 94.26 4.87 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.662 0.744 . . . . 0.0 111.128 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 58.3 mt -71.07 165.49 23.4 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.22 -53.89 48.74 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.3 tp -96.02 113.75 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.331 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.71 -139.67 30.48 Favored Glycine 0 C--O 1.266 2.126 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.392 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.419 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 41.7 p90 -167.69 -176.43 3.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.3 pt-20 -147.31 142.16 26.85 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -89.06 123.87 33.76 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.15 90.0 8.19 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.341 0.591 . . . . 0.0 109.523 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.766 0 CA-C-N 115.78 -0.646 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.31 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 t -132.81 114.88 14.61 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.744 0.783 . . . . 0.0 111.097 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -98.52 109.22 22.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.38 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.25 -32.98 38.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.957 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.1 m -75.06 -21.59 58.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.31 -16.7 34.32 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 121.366 0.603 . . . . 0.0 111.048 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -98.16 92.53 5.79 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.144 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.3 26.6 12.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.97 1.367 . . . . 0.0 110.396 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.7 t30 57.6 37.51 27.53 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.822 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.8 7.02 60.89 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 13.16 82.28 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.9 m -106.43 148.94 27.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.127 0.489 . . . . 0.0 111.601 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.59 -19.23 23.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.595 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -92.37 -172.17 3.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.921 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.9 125.76 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.7 t -98.7 143.16 29.37 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.83 105.65 10.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.54 114.85 17.82 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.96 0.41 . . . . 0.0 111.602 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.23 165.78 12.64 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -72.13 -39.63 68.67 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 tp -117.65 87.5 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.379 1.085 . . . . 0.0 108.933 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.56 -148.55 17.09 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.63 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.9 p90 176.02 165.94 0.4 Allowed 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.93 168.68 19.68 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -119.95 128.89 54.0 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 mt -100.06 -94.86 0.26 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.513 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.198 0 O-C-N 121.887 -0.508 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.96 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 t -152.1 92.59 1.73 Allowed 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.205 0.526 . . . . 0.0 111.152 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.604 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 58.5 t-20 -96.51 97.09 9.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 174.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -69.22 -26.64 64.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 111.854 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 87.5 m -82.88 -17.35 44.11 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.592 0.71 . . . . 0.0 111.434 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.604 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 13.2 tp -71.29 -21.43 62.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -109.69 110.79 21.94 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.192 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 61.18 25.62 15.6 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.251 1.021 . . . . 0.0 113.129 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.1 t30 54.94 34.31 21.99 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.882 1.273 . . . . 0.0 109.92 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 7.38 67.07 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.604 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 4.44 78.89 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.7 m -105.62 148.56 27.2 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -90.39 -20.65 22.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.386 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.91 -167.17 1.55 Allowed 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.079 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.43 113.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.344 0.593 . . . . 0.0 110.439 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.9 t -92.09 135.8 33.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -117.06 112.69 21.26 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.141 0.496 . . . . 0.0 110.168 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.15 110.46 6.63 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.631 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -85.67 178.87 7.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.51 -55.0 13.22 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.44 112.37 39.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.77 -166.3 27.56 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.02 -173.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -162.44 168.21 22.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -135.54 161.15 36.3 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -124.43 129.27 50.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.75 89.32 6.13 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.058 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.3 m -92.42 95.38 9.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.433 0.635 . . . . 0.0 109.541 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.61 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.6 t-20 -87.85 90.6 8.44 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -54.46 -33.23 59.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 56.7 m -63.14 -21.79 66.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.548 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.61 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 44.1 mt -64.0 -34.86 78.97 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.05 98.28 9.93 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 34.81 22.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.295 1.038 . . . . 0.0 112.352 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.5 t30 57.76 37.04 27.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 0.0 109.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.18 84.32 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.68 65.65 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.67 135.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.092 0.472 . . . . 0.0 111.119 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 m -89.15 -10.38 47.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.3 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -108.95 -168.16 1.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.96 117.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.165 0.507 . . . . 0.0 111.313 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -84.18 139.18 32.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -125.8 92.06 3.52 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.754 0.788 . . . . 0.0 108.976 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.19 119.83 19.85 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.56 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.05 170.0 8.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.92 -43.56 87.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 118.677 0.671 . . . . 0.0 109.425 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.55 110.11 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.81 -138.51 35.37 Favored Glycine 0 C--O 1.263 1.967 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.483 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -173.83 -176.74 1.26 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.91 169.96 23.6 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -131.29 149.48 52.54 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.52 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -118.02 101.88 8.61 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.668 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 116.557 -0.292 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.036 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.3 m -72.79 97.54 2.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.575 ' ND2' HD22 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -92.87 79.59 4.67 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -53.89 -38.52 64.88 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.931 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 79.0 m -61.01 -21.77 63.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.575 HD22 ' ND2' ' A' ' 3' ' ' ASN . 2.9 mm? -81.86 -17.35 47.65 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.94 107.05 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.818 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 60.35 28.95 18.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.821 0.819 . . . . 0.0 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 6.3 t30 53.27 41.19 32.14 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.823 1.649 . . . . 0.0 110.801 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.8 80.03 Favored Glycine 0 CA--C 1.504 -0.639 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.346 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.23 70.45 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.5 m -117.36 129.82 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -75.81 -29.15 58.59 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.863 0.363 . . . . 0.0 110.212 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -85.19 -171.15 3.48 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.413 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' HB ' ' N ' ' A' ' 27' ' ' NH2 . 57.6 t -56.86 134.68 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 123.586 0.554 . . . . 0.0 111.838 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.41 148.72 35.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -130.75 102.98 6.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.83 118.96 19.18 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.549 0.69 . . . . 0.0 112.143 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.36 166.55 10.36 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -67.37 -47.61 69.86 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.12 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.93 -141.58 31.91 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.137 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.34 178.75 9.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.23 151.25 40.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.4 m -126.67 134.06 50.8 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.69 -103.82 0.38 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.274 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . 0.426 ' N ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 122.18 -0.325 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.753 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.1 t -97.06 115.32 27.26 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.183 0.992 . . . . 0.0 111.215 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.447 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -105.72 104.52 14.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.056 -176.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.45 -37.56 56.76 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.597 0.759 . . . . 0.0 110.175 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.8 m -58.4 -25.69 62.4 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 63.6 mt -58.79 -39.25 80.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.41 125.32 53.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.748 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.35 19.46 11.7 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.572 1.149 . . . . 0.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.2 t30 58.4 33.05 22.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.156 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.31 6.61 61.87 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.343 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.93 78.78 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.8 m -85.4 128.75 34.82 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -79.41 -21.94 44.93 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.512 0.672 . . . . 0.0 109.31 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -103.79 -167.48 1.38 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.928 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.75 131.24 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 t -98.02 137.6 36.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -124.92 114.69 19.51 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.13 133.68 34.73 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.69 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.93 166.25 12.19 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -55.41 -49.43 72.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.801 0.81 . . . . 0.0 109.368 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.88 131.41 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.79 -138.41 41.76 Favored Glycine 0 C--O 1.263 1.962 0 O-C-N 123.742 0.651 . . . . 0.0 112.671 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -175.23 176.64 2.02 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -144.39 138.52 27.82 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.983 0.42 . . . . 0.0 110.796 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.07 125.43 35.86 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.9 mt -113.8 -99.02 0.43 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.933 0 O-C-N 122.029 -0.419 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -73.25 -29.62 62.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.4 m -63.06 -26.64 68.93 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.4 0.68 . . . . 0.0 111.223 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -62.03 -35.3 78.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.488 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.12 106.85 17.54 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.058 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 62.84 26.79 15.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.05 0.94 . . . . 0.0 112.256 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 58.56 32.16 21.84 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.514 1.126 . . . . 0.0 109.805 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.05 -1.48 40.29 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.156 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.46 5.1 69.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.41 141.26 38.46 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.066 0.46 . . . . 0.0 110.226 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -83.21 -10.2 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.545 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -134.1 -167.5 1.97 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.4 127.26 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.428 0.558 . . . . 0.0 111.614 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.33 149.16 25.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.25 110.35 11.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.14 124.3 27.22 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.24 0.543 . . . . 0.0 111.216 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 73.5 mt -100.72 167.6 10.21 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -66.66 -46.32 76.09 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 tp -109.78 109.55 28.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.935 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.94 -145.33 25.76 Favored Glycine 0 C--O 1.257 1.56 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 30.6 p90 -159.25 175.06 13.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 19' ' ' LEU . 39.1 tt0 -140.18 147.24 39.83 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 123.537 0.523 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -111.49 128.19 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.31 -1.126 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.587 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -73.83 -27.96 61.37 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.749 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.7 m -68.38 -21.16 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.74 -34.51 75.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.47 101.19 12.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.963 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 53.88 38.04 27.84 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.797 1.239 . . . . 0.0 113.474 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.4 t30 62.73 26.2 15.5 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.782 1.233 . . . . 0.0 110.144 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.07 3.71 53.1 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.267 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.72 80.35 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.14 137.56 33.47 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.4 p -85.4 -5.65 59.28 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.941 0.876 . . . . 0.0 110.07 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -129.18 -166.42 1.65 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.05 129.27 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -92.32 145.29 24.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -125.16 108.51 11.85 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.5 112.7 12.09 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.411 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 69.5 mt -96.42 167.65 11.04 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -57.95 -50.69 72.51 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.983 0.802 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.22 132.31 63.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.47 -145.34 49.63 Favored Glycine 0 C--O 1.272 2.481 0 C-N-CA 120.496 -0.859 . . . . 0.0 110.974 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 9.4 p90 -169.54 172.27 7.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -141.78 163.97 31.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.9 m -110.11 135.31 51.11 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -61.16 -36.15 79.03 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.657 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.1 m -65.1 -27.39 68.72 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.13 -30.42 70.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.314 0.578 . . . . 0.0 111.235 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.5 102.89 14.75 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 61.34 27.32 16.99 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.383 0.673 . . . . 0.0 111.801 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.6 t30 58.61 34.2 23.67 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.598 1.159 . . . . 0.0 109.79 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.24 2.82 74.52 Favored Glycine 0 C--O 1.243 0.702 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.811 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 18.57 66.19 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -108.54 144.42 36.24 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.988 0.423 . . . . 0.0 110.835 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -90.4 -7.41 53.27 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.098 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -114.55 -166.69 1.13 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.841 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 60.6 t -59.1 119.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 122.888 0.475 . . . . 0.0 110.919 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -99.76 130.02 45.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.69 110.24 17.62 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 124.888 1.275 . . . . 0.0 107.584 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.43 118.44 21.31 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.925 0.393 . . . . 0.0 111.902 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.5 mt -101.64 166.42 10.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.87 -45.94 87.18 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.479 0.657 . . . . 0.0 110.185 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.93 108.39 25.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.54 -145.75 28.05 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.996 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -162.61 171.85 16.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.148 0.979 . . . . 0.0 108.383 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -135.06 127.22 29.94 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.7 m -109.45 127.67 54.58 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.132 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 4.2 mp . . . . . 0 C--N 1.299 -1.616 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 . . . . . 0 CA--C 1.505 -0.756 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -63.91 -31.82 73.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.709 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.07 -29.47 70.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.46 -29.4 70.69 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.086 0.47 . . . . 0.0 112.12 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.47 107.91 19.08 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 57.92 34.46 24.34 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.95 35.4 21.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.467 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 69.27 10.33 62.42 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.798 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.86 85.7 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.0 m -92.93 134.87 34.67 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -81.31 -23.92 37.52 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -100.07 -170.13 1.83 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.732 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.7 130.69 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.9 t -88.58 143.69 26.79 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -126.24 113.23 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.22 129.82 35.55 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.204 0.526 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.3 mt -107.99 163.92 12.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -68.63 -45.33 72.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -105.47 87.82 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.106 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.33 -138.37 13.82 Favored Glycine 0 C--O 1.259 1.665 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.246 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -170.03 177.07 4.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.6 159.99 36.07 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.63 137.2 42.81 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.311 -1.08 0 CA-C-O 120.731 0.3 . . . . 0.0 110.563 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 48.6 t-20 . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -65.39 -26.95 68.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.251 0.548 . . . . 0.0 111.275 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 71.0 m -72.11 -17.28 61.99 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.089 -176.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 51.4 mt -63.57 -35.83 81.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -106.89 118.35 36.46 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.3 t30 66.72 17.68 10.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.808 1.243 . . . . 0.0 111.334 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.2 t30 57.65 37.41 27.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.321 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.77 -1.18 54.67 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.29 60.92 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.9 m -107.04 145.53 32.25 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.313 0.578 . . . . 0.0 111.107 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.38 -23.25 26.22 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -92.91 -171.72 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.396 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.64 130.87 26.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 122.525 0.33 . . . . 0.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.0 t -113.75 138.54 50.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -129.44 127.88 41.82 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.127 0.489 . . . . 0.0 110.031 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -74.83 131.43 40.76 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.122 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.477 HD21 ' OE2' ' A' ' 24' ' ' GLU . 87.7 mt -110.87 164.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -67.11 -36.27 81.57 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.683 0.754 . . . . 0.0 110.046 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.1 116.19 51.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -146.3 38.86 Favored Glycine 0 C--O 1.268 2.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.343 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -162.45 170.95 17.88 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' OE2' HD21 ' A' ' 19' ' ' LEU . 17.1 pt-20 -133.72 148.22 51.41 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -117.52 121.35 40.74 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.86 -175.181 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 121.542 0.687 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -67.46 -29.11 68.48 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 89.5 m -70.96 -24.4 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.47 -29.14 66.74 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.155 0.503 . . . . 0.0 111.649 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -89.99 108.95 20.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.644 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 58.34 25.95 13.43 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.829 0.852 . . . . 0.0 112.799 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 64.7 t30 61.59 35.43 17.26 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 122.375 1.083 . . . . 0.0 109.19 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 75.48 6.98 82.3 Favored Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.362 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 -1.58 88.78 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.03 145.03 24.95 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.292 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.18 -13.39 35.66 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.992 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -105.82 -168.52 1.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.15 119.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 122.544 0.338 . . . . 0.0 111.019 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.1 t -100.3 122.55 43.27 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -109.06 102.69 11.65 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.14 112.46 6.52 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.907 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.77 166.25 14.76 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.66 -54.05 50.9 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 120.492 1.496 . . . . 0.0 108.981 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tp -111.24 118.66 57.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.03 -160.51 35.21 Favored Glycine 0 C--O 1.272 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -161.22 164.3 30.5 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.71 144.32 48.85 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.9 m -130.79 123.74 29.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.583 0.706 . . . . 0.0 110.978 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--N 1.296 -1.752 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.924 -176.157 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.41 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 46.7 t-20 . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -70.54 -32.44 69.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.305 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.06 -22.7 64.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.988 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 31.8 mt -61.1 -29.02 69.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.174 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -110.82 114.54 27.96 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.46 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 60.26 26.91 16.4 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.0 0.92 . . . . 0.0 112.162 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.61 33.63 20.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.285 1.04 . . . . 0.0 109.155 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.54 -0.26 56.17 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.379 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 1.17 77.57 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.37 132.58 33.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -85.43 -16.52 39.46 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -97.35 -166.4 1.39 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.3 144.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 118.735 0.698 . . . . 0.0 109.881 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -105.91 134.67 48.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -117.11 109.26 16.73 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.95 105.23 12.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.504 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.1 mt -84.48 170.03 13.91 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -58.04 -55.75 30.88 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-N 119.571 1.078 . . . . 0.0 109.539 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.6 pp -109.32 130.25 62.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.44 -149.98 51.01 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.676 -172.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -174.14 176.47 2.51 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.7 151.57 45.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -99.33 129.42 45.54 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 121.061 0.458 . . . . 0.0 110.193 -178.183 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -55.28 -31.25 61.43 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.355 1.062 . . . . 0.0 112.047 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.6 m -61.57 -26.58 68.05 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.017 0.927 . . . . 0.0 111.878 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.36 -25.75 67.72 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.093 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.93 96.77 7.48 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.6 37.06 28.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.305 1.042 . . . . 0.0 111.924 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 61.93 28.96 17.66 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.246 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.13 1.15 67.8 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.669 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.84 24.94 65.76 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.34 144.33 25.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -77.67 -26.33 50.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -120.34 -166.64 1.34 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.488 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.04 131.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.402 0.62 . . . . 0.0 111.993 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.28 145.92 25.6 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.214 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -125.82 124.07 40.13 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -81.65 128.51 34.02 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.321 0.581 . . . . 0.0 112.537 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.6 mt -112.22 162.12 15.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.15 -22.62 48.48 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.896 0.855 . . . . 0.0 109.45 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.97 38.02 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 122.639 1.209 . . . . 0.0 112.292 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.48 -131.15 6.25 Favored Glycine 0 C--N 1.271 -3.038 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.025 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.0 176.77 11.89 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.57 146.0 37.48 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.3 m -108.51 119.03 38.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.018 -176.047 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 . . . . . 0 C--O 1.244 0.764 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -68.68 -27.85 66.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.071 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.0 m -67.73 -26.55 66.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.809 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.38 -28.24 69.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.661 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.87 113.89 27.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.534 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.63 23.2 13.8 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.649 1.214 . . . . 0.0 110.224 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 8.5 t30 57.81 35.13 25.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.901 -1.499 . . . . 0.0 108.859 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 -12.96 30.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.308 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.77 6.98 59.14 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.3 m -95.63 126.31 40.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -74.11 -16.53 61.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 109.517 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -113.19 -166.25 1.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.64 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.52 130.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.06 0.457 . . . . 0.0 110.902 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.77 135.82 40.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 50.7 t30 -116.31 101.45 8.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.3 116.22 15.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.714 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.03 166.84 10.2 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.69 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.632 0.73 . . . . 0.0 110.069 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.47 134.36 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -148.45 50.56 Favored Glycine 0 C--O 1.269 2.327 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.285 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -175.64 166.34 3.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 17' ' ' ASN . 16.8 pt-20 -132.29 151.79 51.68 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.49 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -100.09 124.36 45.38 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 121.137 0.494 . . . . 0.0 110.096 -178.127 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.9 t30 . . . . . 0 CA--C 1.508 -0.644 0 CA-C-O 121.302 0.572 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -73.21 -21.36 60.67 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.524 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 72.9 m -73.4 -23.05 60.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 3' ' ' ASN . 4.1 pp -69.53 -29.38 66.97 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.909 1.337 . . . . 0.0 110.328 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 6' ' ' LEU . 19.9 t70 -88.87 97.5 11.21 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.133 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.58 32.29 18.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.403 1.081 . . . . 0.0 113.192 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 11.2 t30 62.7 32.26 16.25 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 124.434 1.094 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.36 3.57 66.39 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.852 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 5.51 89.77 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.3 m -86.91 132.47 33.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -78.52 -18.52 54.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.459 0.647 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -106.97 -166.52 1.17 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.693 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 62.5 t -59.59 140.65 17.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 120.788 0.328 . . . . 0.0 110.386 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.37 140.59 41.44 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.99 102.28 6.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.63 136.66 56.61 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.388 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.65 167.05 13.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -55.54 -48.31 74.91 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.0 pt -114.2 129.66 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.28 -139.82 48.41 Favored Glycine 0 C--O 1.266 2.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.101 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -169.64 178.82 3.98 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -142.41 147.7 36.61 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.2 m -91.84 141.73 28.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 83.7 mt . . . . . 0 C--N 1.306 -1.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 . . . . . 0 CA--C 1.497 -1.077 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -68.06 -21.56 64.98 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.698 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 84.4 m -76.59 -27.69 55.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.5 mt -67.77 -28.74 67.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.642 0.734 . . . . 0.0 110.602 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.01 103.02 15.66 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.476 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.46 23.6 13.21 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 124.44 1.096 . . . . 0.0 111.027 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.0 t30 60.39 36.68 20.34 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.642 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 5.32 71.7 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.087 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.81 13.7 71.73 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 78.6 m -109.84 144.33 38.45 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.955 0.883 . . . . 0.0 112.442 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.1 m -86.05 -22.85 27.0 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.792 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.5 176.74 7.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.77 132.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.458 0.474 . . . . 0.0 110.4 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -104.15 126.23 51.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -102.02 115.32 30.3 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.66 104.1 11.83 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.884 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 52.7 mt -77.41 160.55 28.66 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -58.95 -54.14 50.53 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.8 pt -104.69 134.18 46.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -153.24 46.49 Favored Glycine 0 C--O 1.278 2.868 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.463 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 36.0 p90 -158.88 173.47 16.47 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -143.31 113.73 7.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.812 0.445 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.29 136.6 32.87 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.693 -0.629 . . . . 0.0 110.531 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.393 -176.925 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.64 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t-20 . . . . . 0 CA--C 1.513 -0.472 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.487 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 23.5 mp0 -50.78 -37.42 42.23 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.071 0.548 . . . . 0.0 112.368 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.92 -23.82 55.08 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.983 0.913 . . . . 0.0 113.253 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 56.4 mt -65.16 -38.28 90.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.442 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.7 102.74 14.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.681 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 58.93 34.08 23.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.048 0.939 . . . . 0.0 112.004 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.2 29.32 17.43 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 -6.88 55.34 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.292 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.04 6.56 56.88 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.7 m -90.28 138.85 31.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -90.11 -21.28 22.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.815 0.817 . . . . 0.0 109.051 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -103.18 -166.19 1.24 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.55 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.22 133.45 25.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.198 0.523 . . . . 0.0 111.256 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -93.44 142.7 27.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.34 105.1 8.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.13 122.92 30.83 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.026 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.0 mt -106.2 166.42 10.53 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.026 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -63.41 -40.41 97.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -109.71 126.38 66.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.15 -136.9 47.9 Favored Glycine 0 C--O 1.271 2.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.307 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 7.4 p90 -175.76 -178.53 1.08 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.19 164.65 38.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.5 m -108.5 130.12 55.27 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.66 -15.02 55.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.423 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 93.3 m -80.86 -23.91 38.75 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 7' ' ' ASP . 3.8 pp -73.22 -30.32 63.41 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 123.101 1.429 . . . . 0.0 109.706 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 6' ' ' LEU . 28.4 t70 -88.54 103.96 16.38 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.554 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.51 24.64 14.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.364 1.078 . . . . 0.0 110.691 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 5.6 t30 57.95 36.49 26.23 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.602 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 72.66 0.73 50.64 Favored Glycine 0 C--O 1.244 0.721 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.91 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.36 89.45 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.7 m -100.53 136.94 39.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.7 p -76.38 -14.67 60.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.045 0.538 . . . . 0.0 112.01 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -111.99 -166.86 1.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.063 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.13 128.69 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 0.0 111.846 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.3 t -111.3 132.06 54.67 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -124.23 112.25 16.81 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -68.64 129.7 40.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.635 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -112.39 164.55 13.13 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.676 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.7 -46.44 90.37 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.688 0.618 . . . . 0.0 110.145 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.7 pp -110.29 123.14 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.63 -142.62 42.51 Favored Glycine 0 C--O 1.271 2.446 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.694 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -167.57 163.27 14.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.18 153.15 39.15 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -125.81 125.34 42.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.591 0.71 . . . . 0.0 109.962 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.299 -1.6 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.358 -177.195 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 13.4 mp0 -70.85 -37.01 73.09 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.865 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.7 m -67.96 -28.12 67.19 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 124.023 0.929 . . . . 0.0 112.223 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -23.16 61.84 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -99.07 89.19 4.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.764 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.98 44.38 28.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.368 1.067 . . . . 0.0 113.139 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 59.99 28.69 18.25 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.888 1.275 . . . . 0.0 110.679 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.32 0.44 53.14 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.034 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.69 84.89 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.9 m -85.65 136.45 33.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.5 t -77.27 -16.44 58.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.959 0.409 . . . . 0.0 110.487 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -123.38 -164.37 1.21 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.734 0.814 . . . . 0.0 108.852 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.3 136.54 17.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 110.12 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.3 t -102.9 145.61 29.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -129.34 104.54 7.56 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.76 118.54 22.38 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.32 166.22 10.57 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.18 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.47 -32.51 48.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.282 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.6 tp -101.34 84.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.79 -132.77 11.49 Favored Glycine 0 C--O 1.253 1.3 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.631 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 22.9 p90 -156.79 177.98 10.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 136.24 21.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 123.068 0.547 . . . . 0.0 110.158 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.88 128.22 48.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 121.345 0.593 . . . . 0.0 109.946 -179.163 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 56.2 t-20 . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.34 -23.96 34.81 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.225 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 82.5 m -81.58 -19.31 42.22 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.721 0.772 . . . . 0.0 111.061 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 5.0 tt -62.26 -41.67 98.65 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.58 106.89 18.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.407 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 61.26 24.5 14.6 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.278 1.031 . . . . 0.0 112.71 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 65.7 t30 56.04 32.58 20.24 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.86 1.264 . . . . 0.0 109.73 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.12 -4.08 19.27 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.251 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.34 19.2 42.73 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.9 m -102.74 135.0 45.21 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -88.58 -14.48 37.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.683 0.754 . . . . 0.0 110.174 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -107.98 -166.67 1.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.64 137.88 23.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -107.33 144.91 33.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.462 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 42.3 t30 -118.17 113.9 22.24 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.43 94.26 4.87 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.662 0.744 . . . . 0.0 111.128 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 58.3 mt -71.07 165.49 23.4 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.22 -53.89 48.74 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.3 tp -96.02 113.75 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.331 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.71 -139.67 30.48 Favored Glycine 0 C--O 1.266 2.126 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.392 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 41.7 p90 -167.69 -176.43 3.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.3 pt-20 -147.31 142.16 26.85 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -89.06 123.87 33.76 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 121.341 0.591 . . . . 0.0 109.523 -177.605 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.25 -32.98 38.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.957 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.1 m -75.06 -21.59 58.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.31 -16.7 34.32 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 121.366 0.603 . . . . 0.0 111.048 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -98.16 92.53 5.79 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.144 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.3 26.6 12.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.97 1.367 . . . . 0.0 110.396 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.7 t30 57.6 37.51 27.53 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.822 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.8 7.02 60.89 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 13.16 82.28 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.9 m -106.43 148.94 27.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.127 0.489 . . . . 0.0 111.601 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.59 -19.23 23.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.595 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -92.37 -172.17 3.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.921 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.9 125.76 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.7 t -98.7 143.16 29.37 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.83 105.65 10.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.54 114.85 17.82 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.96 0.41 . . . . 0.0 111.602 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.23 165.78 12.64 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -72.13 -39.63 68.67 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 tp -117.65 87.5 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.379 1.085 . . . . 0.0 108.933 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.56 -148.55 17.09 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.63 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.9 p90 176.02 165.94 0.4 Allowed 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.93 168.68 19.68 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -119.95 128.89 54.0 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.513 -175.389 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 58.5 t-20 . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -69.22 -26.64 64.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 111.854 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 87.5 m -82.88 -17.35 44.11 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.592 0.71 . . . . 0.0 111.434 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.621 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 13.2 tp -71.29 -21.43 62.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -109.69 110.79 21.94 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.192 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 61.18 25.62 15.6 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.251 1.021 . . . . 0.0 113.129 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.1 t30 54.94 34.31 21.99 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.882 1.273 . . . . 0.0 109.92 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 7.38 67.07 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.604 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 4.44 78.89 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.7 m -105.62 148.56 27.2 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -90.39 -20.65 22.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.386 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.91 -167.17 1.55 Allowed 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.079 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.43 113.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.344 0.593 . . . . 0.0 110.439 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.9 t -92.09 135.8 33.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -117.06 112.69 21.26 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.141 0.496 . . . . 0.0 110.168 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.15 110.46 6.63 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.631 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 62.0 mt -85.67 178.87 7.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.51 -55.0 13.22 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.44 112.37 39.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.77 -166.3 27.56 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.02 -173.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.409 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 21.3 p90 -162.44 168.21 22.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -135.54 161.15 36.3 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -124.43 129.27 50.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.058 -178.006 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.62 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.6 t-20 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -54.46 -33.23 59.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 56.7 m -63.14 -21.79 66.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.548 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.62 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 44.1 mt -64.0 -34.86 78.97 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.05 98.28 9.93 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 34.81 22.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.295 1.038 . . . . 0.0 112.352 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.5 t30 57.76 37.04 27.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 0.0 109.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.18 84.32 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.68 65.65 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.67 135.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.092 0.472 . . . . 0.0 111.119 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 m -89.15 -10.38 47.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.3 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -108.95 -168.16 1.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.96 117.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.165 0.507 . . . . 0.0 111.313 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -84.18 139.18 32.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -125.8 92.06 3.52 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.754 0.788 . . . . 0.0 108.976 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.19 119.83 19.85 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.56 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.05 170.0 8.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.92 -43.56 87.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 118.677 0.671 . . . . 0.0 109.425 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.55 110.11 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.81 -138.51 35.37 Favored Glycine 0 C--O 1.263 1.967 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.483 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -173.83 -176.74 1.26 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.91 169.96 23.6 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -131.29 149.48 52.54 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.52 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.668 -175.049 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.436 ' OD1' HD23 ' A' ' 6' ' ' LEU . 37.6 t-20 . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -53.89 -38.52 64.88 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.931 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 79.0 m -61.01 -21.77 63.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.436 HD23 ' OD1' ' A' ' 3' ' ' ASN . 2.9 mm? -81.86 -17.35 47.65 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.94 107.05 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.818 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 60.35 28.95 18.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.821 0.819 . . . . 0.0 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 6.3 t30 53.27 41.19 32.14 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.823 1.649 . . . . 0.0 110.801 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.8 80.03 Favored Glycine 0 CA--C 1.504 -0.639 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.346 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.23 70.45 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.5 m -117.36 129.82 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -75.81 -29.15 58.59 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.863 0.363 . . . . 0.0 110.212 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.403 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 3.0 p80 -85.19 -171.15 3.48 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.413 174.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 14' ' ' HIS . 57.6 t -56.86 134.68 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 123.586 0.554 . . . . 0.0 111.838 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.41 148.72 35.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -130.75 102.98 6.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.83 118.96 19.18 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.549 0.69 . . . . 0.0 112.143 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.36 166.55 10.36 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -67.37 -47.61 69.86 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.12 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.93 -141.58 31.91 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.137 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.34 178.75 9.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.23 151.25 40.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.4 m -126.67 134.06 50.8 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.274 -173.409 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.449 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 34.5 t-20 . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.45 -37.56 56.76 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.597 0.759 . . . . 0.0 110.175 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.8 m -58.4 -25.69 62.4 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 63.6 mt -58.79 -39.25 80.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.41 125.32 53.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.748 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.35 19.46 11.7 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.572 1.149 . . . . 0.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.2 t30 58.4 33.05 22.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.156 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.31 6.61 61.87 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.343 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.93 78.78 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.8 m -85.4 128.75 34.82 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -79.41 -21.94 44.93 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.512 0.672 . . . . 0.0 109.31 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -103.79 -167.48 1.38 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.928 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.75 131.24 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 t -98.02 137.6 36.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 46.9 t30 -124.92 114.69 19.51 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.13 133.68 34.73 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.69 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.93 166.25 12.19 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -55.41 -49.43 72.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.801 0.81 . . . . 0.0 109.368 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.88 131.41 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.79 -138.41 41.76 Favored Glycine 0 C--O 1.263 1.962 0 O-C-N 123.742 0.651 . . . . 0.0 112.671 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -175.23 176.64 2.02 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 17' ' ' ASN . 22.3 pt-20 -144.39 138.52 27.82 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.983 0.42 . . . . 0.0 110.796 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.07 125.43 35.86 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.606 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.368 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 t -163.13 140.54 7.69 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -93.9 109.88 21.57 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.571 0.224 . . . . 0.0 110.735 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -73.25 -29.62 62.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.4 m -63.06 -26.64 68.93 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.4 0.68 . . . . 0.0 111.223 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -62.03 -35.3 78.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.488 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.12 106.85 17.54 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.058 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 62.84 26.79 15.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.05 0.94 . . . . 0.0 112.256 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 58.56 32.16 21.84 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.514 1.126 . . . . 0.0 109.805 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.05 -1.48 40.29 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.156 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.46 5.1 69.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.41 141.26 38.46 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.066 0.46 . . . . 0.0 110.226 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -83.21 -10.2 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.545 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -134.1 -167.5 1.97 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.4 127.26 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.428 0.558 . . . . 0.0 111.614 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.33 149.16 25.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.25 110.35 11.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.14 124.3 27.22 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.24 0.543 . . . . 0.0 111.216 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 73.5 mt -100.72 167.6 10.21 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -66.66 -46.32 76.09 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 tp -109.78 109.55 28.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.935 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.94 -145.33 25.76 Favored Glycine 0 C--O 1.257 1.56 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 30.6 p90 -159.25 175.06 13.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 19' ' ' LEU . 39.1 tt0 -140.18 147.24 39.83 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 123.537 0.523 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -111.49 128.19 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.94 -99.88 0.43 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.998 0 O-C-N 122.022 -0.424 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.879 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 t -116.97 96.9 5.67 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.986 0.898 . . . . 0.0 112.043 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -95.61 108.55 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -73.83 -27.96 61.37 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.749 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.7 m -68.38 -21.16 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.74 -34.51 75.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.47 101.19 12.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.963 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 53.88 38.04 27.84 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.797 1.239 . . . . 0.0 113.474 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.4 t30 62.73 26.2 15.5 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.782 1.233 . . . . 0.0 110.144 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.07 3.71 53.1 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.267 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.72 80.35 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.14 137.56 33.47 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.4 p -85.4 -5.65 59.28 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.941 0.876 . . . . 0.0 110.07 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -129.18 -166.42 1.65 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.05 129.27 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -92.32 145.29 24.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -125.16 108.51 11.85 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.5 112.7 12.09 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.411 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 69.5 mt -96.42 167.65 11.04 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -57.95 -50.69 72.51 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.983 0.802 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.22 132.31 63.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.47 -145.34 49.63 Favored Glycine 0 C--O 1.272 2.481 0 C-N-CA 120.496 -0.859 . . . . 0.0 110.974 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 9.4 p90 -169.54 172.27 7.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -141.78 163.97 31.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.9 m -110.11 135.31 51.11 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -116.47 -90.59 0.55 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.143 0 O-C-N 122.3 -0.25 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -94.22 140.91 29.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -99.09 89.88 4.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -61.16 -36.15 79.03 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.657 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.1 m -65.1 -27.39 68.72 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.13 -30.42 70.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.314 0.578 . . . . 0.0 111.235 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.5 102.89 14.75 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 61.34 27.32 16.99 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.383 0.673 . . . . 0.0 111.801 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.6 t30 58.61 34.2 23.67 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.598 1.159 . . . . 0.0 109.79 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.24 2.82 74.52 Favored Glycine 0 C--O 1.243 0.702 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.811 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 18.57 66.19 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -108.54 144.42 36.24 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.988 0.423 . . . . 0.0 110.835 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -90.4 -7.41 53.27 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.098 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -114.55 -166.69 1.13 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.841 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 60.6 t -59.1 119.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 122.888 0.475 . . . . 0.0 110.919 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -99.76 130.02 45.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.69 110.24 17.62 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 124.888 1.275 . . . . 0.0 107.584 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.43 118.44 21.31 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.925 0.393 . . . . 0.0 111.902 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.5 mt -101.64 166.42 10.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.87 -45.94 87.18 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.479 0.657 . . . . 0.0 110.185 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.93 108.39 25.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.54 -145.75 28.05 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.996 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -162.61 171.85 16.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.148 0.979 . . . . 0.0 108.383 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -135.06 127.22 29.94 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.7 m -109.45 127.67 54.58 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.132 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 4.2 mp -104.52 96.9 6.92 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 116.56 -0.291 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.462 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.1 m -65.77 136.82 56.73 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.327 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -104.19 95.96 6.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -63.91 -31.82 73.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.709 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.07 -29.47 70.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.46 -29.4 70.69 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.086 0.47 . . . . 0.0 112.12 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.47 107.91 19.08 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 57.92 34.46 24.34 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.95 35.4 21.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.467 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 69.27 10.33 62.42 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.798 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.86 85.7 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.0 m -92.93 134.87 34.67 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -81.31 -23.92 37.52 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -100.07 -170.13 1.83 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.732 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.7 130.69 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.9 t -88.58 143.69 26.79 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -126.24 113.23 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.22 129.82 35.55 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.204 0.526 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.3 mt -107.99 163.92 12.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -68.63 -45.33 72.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -105.47 87.82 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.106 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.33 -138.37 13.82 Favored Glycine 0 C--O 1.259 1.665 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.246 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -170.03 177.07 4.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.6 159.99 36.07 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.63 137.2 42.81 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -119.17 -89.63 0.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.731 0.3 . . . . 0.0 110.563 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.035 0 O-C-N 122.185 -0.322 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.5 m -94.25 121.72 36.04 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 48.6 t-20 -94.62 98.15 10.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -65.39 -26.95 68.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.251 0.548 . . . . 0.0 111.275 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 71.0 m -72.11 -17.28 61.99 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.089 -176.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 51.4 mt -63.57 -35.83 81.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -106.89 118.35 36.46 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.3 t30 66.72 17.68 10.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.808 1.243 . . . . 0.0 111.334 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.2 t30 57.65 37.41 27.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.321 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.77 -1.18 54.67 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.29 60.92 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.9 m -107.04 145.53 32.25 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.313 0.578 . . . . 0.0 111.107 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.38 -23.25 26.22 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -92.91 -171.72 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.396 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.64 130.87 26.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 122.525 0.33 . . . . 0.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.0 t -113.75 138.54 50.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -129.44 127.88 41.82 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.127 0.489 . . . . 0.0 110.031 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -74.83 131.43 40.76 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.122 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.477 HD21 ' OE2' ' A' ' 24' ' ' GLU . 87.7 mt -110.87 164.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -67.11 -36.27 81.57 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.683 0.754 . . . . 0.0 110.046 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.1 116.19 51.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -146.3 38.86 Favored Glycine 0 C--O 1.268 2.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.343 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -162.45 170.95 17.88 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' OE2' HD21 ' A' ' 19' ' ' LEU . 17.1 pt-20 -133.72 148.22 51.41 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -117.52 121.35 40.74 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.71 92.86 7.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.86 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 116.392 -0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.92 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -89.44 82.8 6.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -108.73 93.87 4.75 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.542 0.687 . . . . 0.0 109.945 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -67.46 -29.11 68.48 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 89.5 m -70.96 -24.4 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.47 -29.14 66.74 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.155 0.503 . . . . 0.0 111.649 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -89.99 108.95 20.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.644 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 58.34 25.95 13.43 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.829 0.852 . . . . 0.0 112.799 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 64.7 t30 61.59 35.43 17.26 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 122.375 1.083 . . . . 0.0 109.19 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 75.48 6.98 82.3 Favored Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.362 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 -1.58 88.78 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.03 145.03 24.95 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.292 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.18 -13.39 35.66 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.992 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -105.82 -168.52 1.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.15 119.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 122.544 0.338 . . . . 0.0 111.019 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.1 t -100.3 122.55 43.27 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -109.06 102.69 11.65 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.14 112.46 6.52 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.907 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.77 166.25 14.76 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.66 -54.05 50.9 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 120.492 1.496 . . . . 0.0 108.981 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tp -111.24 118.66 57.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.03 -160.51 35.21 Favored Glycine 0 C--O 1.272 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -161.22 164.3 30.5 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.71 144.32 48.85 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.9 m -130.79 123.74 29.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.583 0.706 . . . . 0.0 110.978 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.68 97.95 6.58 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.924 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 CA-C-N 116.556 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.756 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -88.21 107.07 18.6 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.479 0.657 . . . . 0.0 111.272 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.41 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 46.7 t-20 -107.22 102.35 11.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -70.54 -32.44 69.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.305 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.06 -22.7 64.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.988 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 31.8 mt -61.1 -29.02 69.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.174 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -110.82 114.54 27.96 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.46 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 60.26 26.91 16.4 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.0 0.92 . . . . 0.0 112.162 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.61 33.63 20.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.285 1.04 . . . . 0.0 109.155 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.54 -0.26 56.17 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.379 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 1.17 77.57 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.37 132.58 33.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -85.43 -16.52 39.46 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -97.35 -166.4 1.39 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.3 144.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 118.735 0.698 . . . . 0.0 109.881 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -105.91 134.67 48.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -117.11 109.26 16.73 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.95 105.23 12.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.504 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.1 mt -84.48 170.03 13.91 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -58.04 -55.75 30.88 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-N 119.571 1.078 . . . . 0.0 109.539 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.6 pp -109.32 130.25 62.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.44 -149.98 51.01 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.676 -172.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -174.14 176.47 2.51 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.7 151.57 45.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -99.33 129.42 45.54 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.5 mt -107.06 96.15 6.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.061 0.458 . . . . 0.0 110.193 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.209 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t -59.37 121.68 12.05 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.994 0.902 . . . . 0.0 109.764 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -103.29 95.12 5.89 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.227 -170.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -55.28 -31.25 61.43 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.355 1.062 . . . . 0.0 112.047 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.6 m -61.57 -26.58 68.05 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.017 0.927 . . . . 0.0 111.878 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 mt -65.36 -25.75 67.72 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.093 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.93 96.77 7.48 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 t30 56.6 37.06 28.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.305 1.042 . . . . 0.0 111.924 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 61.93 28.96 17.66 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.246 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.13 1.15 67.8 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.669 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.84 24.94 65.76 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.34 144.33 25.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -77.67 -26.33 50.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -120.34 -166.64 1.34 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.488 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.04 131.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.402 0.62 . . . . 0.0 111.993 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.28 145.92 25.6 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.214 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -125.82 124.07 40.13 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -81.65 128.51 34.02 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.321 0.581 . . . . 0.0 112.537 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.6 mt -112.22 162.12 15.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.15 -22.62 48.48 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.896 0.855 . . . . 0.0 109.45 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.97 38.02 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 122.639 1.209 . . . . 0.0 112.292 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.48 -131.15 6.25 Favored Glycine 0 C--N 1.271 -3.038 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.025 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.0 176.77 11.89 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.57 146.0 37.48 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.3 m -108.51 119.03 38.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.54 79.52 6.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.018 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.557 0 CA-C-N 116.053 -0.521 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 t -84.87 109.87 18.43 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.161 0.981 . . . . 0.0 112.69 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -100.34 100.61 11.43 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -68.68 -27.85 66.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.071 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.0 m -67.73 -26.55 66.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.809 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.38 -28.24 69.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.661 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.87 113.89 27.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.534 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.63 23.2 13.8 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.649 1.214 . . . . 0.0 110.224 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 8.5 t30 57.81 35.13 25.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.901 -1.499 . . . . 0.0 108.859 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 -12.96 30.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.308 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.77 6.98 59.14 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.3 m -95.63 126.31 40.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -74.11 -16.53 61.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 109.517 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -113.19 -166.25 1.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.64 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.52 130.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.06 0.457 . . . . 0.0 110.902 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.77 135.82 40.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 50.7 t30 -116.31 101.45 8.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.3 116.22 15.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.714 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.03 166.84 10.2 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.69 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.632 0.73 . . . . 0.0 110.069 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.47 134.36 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -148.45 50.56 Favored Glycine 0 C--O 1.269 2.327 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.285 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -175.64 166.34 3.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 17' ' ' ASN . 16.8 pt-20 -132.29 151.79 51.68 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.49 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -100.09 124.36 45.38 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.6 93.06 8.76 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.137 0.494 . . . . 0.0 110.096 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.461 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -79.97 89.29 5.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.9 t30 -90.97 107.79 19.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.302 0.572 . . . . 0.0 110.782 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -73.21 -21.36 60.67 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.524 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 72.9 m -73.4 -23.05 60.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 3' ' ' ASN . 4.1 pp -69.53 -29.38 66.97 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.909 1.337 . . . . 0.0 110.328 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 6' ' ' LEU . 19.9 t70 -88.87 97.5 11.21 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.133 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.58 32.29 18.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.403 1.081 . . . . 0.0 113.192 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 11.2 t30 62.7 32.26 16.25 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 124.434 1.094 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.36 3.57 66.39 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.852 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 5.51 89.77 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.3 m -86.91 132.47 33.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -78.52 -18.52 54.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.459 0.647 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -106.97 -166.52 1.17 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.693 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 62.5 t -59.59 140.65 17.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 120.788 0.328 . . . . 0.0 110.386 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.37 140.59 41.44 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.99 102.28 6.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.63 136.66 56.61 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.388 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.65 167.05 13.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -55.54 -48.31 74.91 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.0 pt -114.2 129.66 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.28 -139.82 48.41 Favored Glycine 0 C--O 1.266 2.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.101 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -169.64 178.82 3.98 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -142.41 147.7 36.61 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.2 m -91.84 141.73 28.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 83.7 mt -110.75 96.42 6.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.316 0 CA-C-N 116.607 -0.27 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.179 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 2' ' ' THR . 19.3 m -106.56 28.72 7.56 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.009 1.385 . . . . 0.0 111.551 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -112.65 87.87 2.69 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -68.06 -21.56 64.98 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.698 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 84.4 m -76.59 -27.69 55.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.5 mt -67.77 -28.74 67.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.642 0.734 . . . . 0.0 110.602 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.01 103.02 15.66 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.476 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.46 23.6 13.21 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 124.44 1.096 . . . . 0.0 111.027 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.0 t30 60.39 36.68 20.34 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.642 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 5.32 71.7 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.087 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.81 13.7 71.73 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 78.6 m -109.84 144.33 38.45 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.955 0.883 . . . . 0.0 112.442 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.1 m -86.05 -22.85 27.0 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.792 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.5 176.74 7.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.77 132.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.458 0.474 . . . . 0.0 110.4 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -104.15 126.23 51.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -102.02 115.32 30.3 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.66 104.1 11.83 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.884 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 52.7 mt -77.41 160.55 28.66 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -58.95 -54.14 50.53 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.8 pt -104.69 134.18 46.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -153.24 46.49 Favored Glycine 0 C--O 1.278 2.868 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.463 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 36.0 p90 -158.88 173.47 16.47 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -143.31 113.73 7.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.812 0.445 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.29 136.6 32.87 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.693 -0.629 . . . . 0.0 110.531 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.41 -93.55 0.52 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.393 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.816 0 O-C-N 122.067 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.721 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 m -82.65 115.62 21.68 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.64 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t-20 -98.36 82.33 2.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.487 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 23.5 mp0 -50.78 -37.42 42.23 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.071 0.548 . . . . 0.0 112.368 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.92 -23.82 55.08 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.983 0.913 . . . . 0.0 113.253 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 56.4 mt -65.16 -38.28 90.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.442 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.7 102.74 14.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.681 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 58.93 34.08 23.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.048 0.939 . . . . 0.0 112.004 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.2 29.32 17.43 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 -6.88 55.34 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.292 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.04 6.56 56.88 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.7 m -90.28 138.85 31.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -90.11 -21.28 22.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.815 0.817 . . . . 0.0 109.051 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -103.18 -166.19 1.24 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.55 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.22 133.45 25.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.198 0.523 . . . . 0.0 111.256 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -93.44 142.7 27.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.34 105.1 8.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.13 122.92 30.83 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.026 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.0 mt -106.2 166.42 10.53 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.026 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -63.41 -40.41 97.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -109.71 126.38 66.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.15 -136.9 47.9 Favored Glycine 0 C--O 1.271 2.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.307 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 7.4 p90 -175.76 -178.53 1.08 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.19 164.65 38.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.5 m -108.5 130.12 55.27 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.71 93.54 4.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.725 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.8 m -77.45 130.55 37.18 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 122.87 0.468 . . . . 0.0 110.008 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.51 99.59 12.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.66 -15.02 55.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.423 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 93.3 m -80.86 -23.91 38.75 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 7' ' ' ASP . 3.8 pp -73.22 -30.32 63.41 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 123.101 1.429 . . . . 0.0 109.706 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 6' ' ' LEU . 28.4 t70 -88.54 103.96 16.38 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.554 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.51 24.64 14.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.364 1.078 . . . . 0.0 110.691 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 5.6 t30 57.95 36.49 26.23 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.602 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 72.66 0.73 50.64 Favored Glycine 0 C--O 1.244 0.721 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.91 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.36 89.45 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.7 m -100.53 136.94 39.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.7 p -76.38 -14.67 60.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.045 0.538 . . . . 0.0 112.01 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -111.99 -166.86 1.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.063 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.13 128.69 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 0.0 111.846 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.3 t -111.3 132.06 54.67 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -124.23 112.25 16.81 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -68.64 129.7 40.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.635 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -112.39 164.55 13.13 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.676 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.7 -46.44 90.37 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.688 0.618 . . . . 0.0 110.145 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.7 pp -110.29 123.14 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.63 -142.62 42.51 Favored Glycine 0 C--O 1.271 2.446 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.694 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -167.57 163.27 14.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.18 153.15 39.15 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -125.81 125.34 42.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.591 0.71 . . . . 0.0 109.962 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.56 87.72 2.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.358 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.613 0 CA-C-N 116.066 -0.515 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.385 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.4 m -78.59 88.81 4.51 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.811 0.815 . . . . 0.0 108.803 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -89.26 109.97 20.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.226 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 13.4 mp0 -70.85 -37.01 73.09 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.865 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.7 m -67.96 -28.12 67.19 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 124.023 0.929 . . . . 0.0 112.223 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -23.16 61.84 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -99.07 89.19 4.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.764 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.98 44.38 28.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.368 1.067 . . . . 0.0 113.139 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 59.99 28.69 18.25 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.888 1.275 . . . . 0.0 110.679 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.32 0.44 53.14 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.034 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.69 84.89 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.9 m -85.65 136.45 33.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.5 t -77.27 -16.44 58.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.959 0.409 . . . . 0.0 110.487 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -123.38 -164.37 1.21 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.734 0.814 . . . . 0.0 108.852 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.3 136.54 17.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 110.12 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.3 t -102.9 145.61 29.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -129.34 104.54 7.56 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.76 118.54 22.38 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.32 166.22 10.57 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.18 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.47 -32.51 48.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.282 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.6 tp -101.34 84.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.79 -132.77 11.49 Favored Glycine 0 C--O 1.253 1.3 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.631 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 22.9 p90 -156.79 177.98 10.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 136.24 21.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 123.068 0.547 . . . . 0.0 110.158 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.88 128.22 48.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.2 mt -103.06 77.68 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.345 0.593 . . . . 0.0 109.946 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 116.132 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.391 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -81.99 89.77 6.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.693 1.235 . . . . 0.0 109.256 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 56.2 t-20 -87.33 110.41 20.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.632 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.34 -23.96 34.81 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.225 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 82.5 m -81.58 -19.31 42.22 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.721 0.772 . . . . 0.0 111.061 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 5.0 tt -62.26 -41.67 98.65 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.58 106.89 18.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.407 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 61.26 24.5 14.6 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.278 1.031 . . . . 0.0 112.71 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 65.7 t30 56.04 32.58 20.24 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.86 1.264 . . . . 0.0 109.73 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.12 -4.08 19.27 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.251 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.34 19.2 42.73 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.9 m -102.74 135.0 45.21 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -88.58 -14.48 37.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.683 0.754 . . . . 0.0 110.174 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -107.98 -166.67 1.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.64 137.88 23.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -107.33 144.91 33.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.462 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 42.3 t30 -118.17 113.9 22.24 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.43 94.26 4.87 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.662 0.744 . . . . 0.0 111.128 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 58.3 mt -71.07 165.49 23.4 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.22 -53.89 48.74 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.3 tp -96.02 113.75 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.331 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.71 -139.67 30.48 Favored Glycine 0 C--O 1.266 2.126 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.392 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 41.7 p90 -167.69 -176.43 3.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.3 pt-20 -147.31 142.16 26.85 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -89.06 123.87 33.76 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.15 90.0 8.19 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.341 0.591 . . . . 0.0 109.523 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.766 0 CA-C-N 115.78 -0.646 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.31 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 t -132.81 114.88 14.61 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.744 0.783 . . . . 0.0 111.097 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -98.52 109.22 22.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.38 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.25 -32.98 38.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.957 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.1 m -75.06 -21.59 58.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.31 -16.7 34.32 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 121.366 0.603 . . . . 0.0 111.048 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -98.16 92.53 5.79 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.144 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.3 26.6 12.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.97 1.367 . . . . 0.0 110.396 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.7 t30 57.6 37.51 27.53 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.822 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.8 7.02 60.89 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 13.16 82.28 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.9 m -106.43 148.94 27.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.127 0.489 . . . . 0.0 111.601 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.59 -19.23 23.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.595 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -92.37 -172.17 3.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.921 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.9 125.76 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.7 t -98.7 143.16 29.37 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.83 105.65 10.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.54 114.85 17.82 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.96 0.41 . . . . 0.0 111.602 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.23 165.78 12.64 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -72.13 -39.63 68.67 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 tp -117.65 87.5 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.379 1.085 . . . . 0.0 108.933 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.56 -148.55 17.09 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.63 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.9 p90 176.02 165.94 0.4 Allowed 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.93 168.68 19.68 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -119.95 128.89 54.0 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 mt -100.06 -94.86 0.26 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.513 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.198 0 O-C-N 121.887 -0.508 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.96 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 t -152.1 92.59 1.73 Allowed 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.205 0.526 . . . . 0.0 111.152 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 58.5 t-20 -96.51 97.09 9.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 174.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -69.22 -26.64 64.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 111.854 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 87.5 m -82.88 -17.35 44.11 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.592 0.71 . . . . 0.0 111.434 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.621 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 13.2 tp -71.29 -21.43 62.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -109.69 110.79 21.94 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.192 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 61.18 25.62 15.6 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.251 1.021 . . . . 0.0 113.129 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.1 t30 54.94 34.31 21.99 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.882 1.273 . . . . 0.0 109.92 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 7.38 67.07 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.604 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 4.44 78.89 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.7 m -105.62 148.56 27.2 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -90.39 -20.65 22.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.386 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.91 -167.17 1.55 Allowed 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.079 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.43 113.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.344 0.593 . . . . 0.0 110.439 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.9 t -92.09 135.8 33.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -117.06 112.69 21.26 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.141 0.496 . . . . 0.0 110.168 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.15 110.46 6.63 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.631 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 62.0 mt -85.67 178.87 7.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.51 -55.0 13.22 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.44 112.37 39.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.77 -166.3 27.56 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.02 -173.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 21.3 p90 -162.44 168.21 22.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -135.54 161.15 36.3 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -124.43 129.27 50.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.75 89.32 6.13 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.058 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.3 m -92.42 95.38 9.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.433 0.635 . . . . 0.0 109.541 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.62 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.6 t-20 -87.85 90.6 8.44 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -54.46 -33.23 59.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 56.7 m -63.14 -21.79 66.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.548 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.62 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 44.1 mt -64.0 -34.86 78.97 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.05 98.28 9.93 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 34.81 22.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.295 1.038 . . . . 0.0 112.352 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.5 t30 57.76 37.04 27.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 0.0 109.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.18 84.32 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.68 65.65 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.67 135.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.092 0.472 . . . . 0.0 111.119 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 m -89.15 -10.38 47.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.3 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -108.95 -168.16 1.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.96 117.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.165 0.507 . . . . 0.0 111.313 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -84.18 139.18 32.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -125.8 92.06 3.52 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.754 0.788 . . . . 0.0 108.976 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.19 119.83 19.85 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.56 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.05 170.0 8.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.92 -43.56 87.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 118.677 0.671 . . . . 0.0 109.425 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.55 110.11 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.81 -138.51 35.37 Favored Glycine 0 C--O 1.263 1.967 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.483 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -173.83 -176.74 1.26 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.91 169.96 23.6 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -131.29 149.48 52.54 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.52 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -118.02 101.88 8.61 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.668 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 116.557 -0.292 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.036 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.3 m -72.79 97.54 2.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.436 ' OD1' HD23 ' A' ' 6' ' ' LEU . 37.6 t-20 -92.87 79.59 4.67 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -53.89 -38.52 64.88 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.931 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 79.0 m -61.01 -21.77 63.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.436 HD23 ' OD1' ' A' ' 3' ' ' ASN . 2.9 mm? -81.86 -17.35 47.65 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.94 107.05 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.818 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 60.35 28.95 18.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.821 0.819 . . . . 0.0 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 6.3 t30 53.27 41.19 32.14 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.823 1.649 . . . . 0.0 110.801 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.8 80.03 Favored Glycine 0 CA--C 1.504 -0.639 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.346 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.23 70.45 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.5 m -117.36 129.82 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -75.81 -29.15 58.59 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.863 0.363 . . . . 0.0 110.212 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.403 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 3.0 p80 -85.19 -171.15 3.48 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.413 174.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.436 ' HB ' ' N ' ' A' ' 27' ' ' NH2 . 57.6 t -56.86 134.68 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 123.586 0.554 . . . . 0.0 111.838 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.41 148.72 35.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -130.75 102.98 6.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.83 118.96 19.18 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.549 0.69 . . . . 0.0 112.143 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.36 166.55 10.36 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -67.37 -47.61 69.86 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.12 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.93 -141.58 31.91 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.137 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.34 178.75 9.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.23 151.25 40.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.4 m -126.67 134.06 50.8 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.69 -103.82 0.38 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.274 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . 0.436 ' N ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 122.18 -0.325 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.753 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.1 t -97.06 115.32 27.26 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.183 0.992 . . . . 0.0 111.215 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.449 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 34.5 t-20 -105.72 104.52 14.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.056 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.45 -37.56 56.76 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.597 0.759 . . . . 0.0 110.175 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.8 m -58.4 -25.69 62.4 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 63.6 mt -58.79 -39.25 80.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.41 125.32 53.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.748 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.35 19.46 11.7 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.572 1.149 . . . . 0.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.2 t30 58.4 33.05 22.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.156 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.31 6.61 61.87 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.343 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.93 78.78 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.8 m -85.4 128.75 34.82 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -79.41 -21.94 44.93 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.512 0.672 . . . . 0.0 109.31 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -103.79 -167.48 1.38 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.928 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.75 131.24 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 t -98.02 137.6 36.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 46.9 t30 -124.92 114.69 19.51 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.13 133.68 34.73 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.69 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.93 166.25 12.19 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -55.41 -49.43 72.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.801 0.81 . . . . 0.0 109.368 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.88 131.41 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.79 -138.41 41.76 Favored Glycine 0 C--O 1.263 1.962 0 O-C-N 123.742 0.651 . . . . 0.0 112.671 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -175.23 176.64 2.02 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 17' ' ' ASN . 22.3 pt-20 -144.39 138.52 27.82 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.983 0.42 . . . . 0.0 110.796 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.07 125.43 35.86 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.9 mt -113.8 -99.02 0.43 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.933 0 O-C-N 122.029 -0.419 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.571 0.224 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -73.25 -29.62 62.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.4 m -63.06 -26.64 68.93 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.4 0.68 . . . . 0.0 111.223 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -62.03 -35.3 78.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.488 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.12 106.85 17.54 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.058 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 62.84 26.79 15.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.05 0.94 . . . . 0.0 112.256 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 58.56 32.16 21.84 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.514 1.126 . . . . 0.0 109.805 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.05 -1.48 40.29 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.156 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.46 5.1 69.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.41 141.26 38.46 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.066 0.46 . . . . 0.0 110.226 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -83.21 -10.2 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.545 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -134.1 -167.5 1.97 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.4 127.26 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.428 0.558 . . . . 0.0 111.614 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.33 149.16 25.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.25 110.35 11.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.14 124.3 27.22 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.24 0.543 . . . . 0.0 111.216 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 73.5 mt -100.72 167.6 10.21 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -66.66 -46.32 76.09 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 tp -109.78 109.55 28.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.935 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.94 -145.33 25.76 Favored Glycine 0 C--O 1.257 1.56 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 30.6 p90 -159.25 175.06 13.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 19' ' ' LEU . 39.1 tt0 -140.18 147.24 39.83 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 123.537 0.523 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -111.49 128.19 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 C--N 1.31 -1.126 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.587 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 . . . . . 0 N--CA 1.44 -0.947 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -73.83 -27.96 61.37 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.749 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.7 m -68.38 -21.16 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.74 -34.51 75.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.47 101.19 12.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.963 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 53.88 38.04 27.84 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.797 1.239 . . . . 0.0 113.474 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.4 t30 62.73 26.2 15.5 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.782 1.233 . . . . 0.0 110.144 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.07 3.71 53.1 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.267 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.72 80.35 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.14 137.56 33.47 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.4 p -85.4 -5.65 59.28 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.941 0.876 . . . . 0.0 110.07 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -129.18 -166.42 1.65 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.05 129.27 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -92.32 145.29 24.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -125.16 108.51 11.85 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.5 112.7 12.09 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.411 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 69.5 mt -96.42 167.65 11.04 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -57.95 -50.69 72.51 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.983 0.802 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.22 132.31 63.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.47 -145.34 49.63 Favored Glycine 0 C--O 1.272 2.481 0 C-N-CA 120.496 -0.859 . . . . 0.0 110.974 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 9.4 p90 -169.54 172.27 7.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -141.78 163.97 31.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.9 m -110.11 135.31 51.11 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.505 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -61.16 -36.15 79.03 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.657 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.1 m -65.1 -27.39 68.72 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.13 -30.42 70.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.314 0.578 . . . . 0.0 111.235 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.5 102.89 14.75 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 61.34 27.32 16.99 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.383 0.673 . . . . 0.0 111.801 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.6 t30 58.61 34.2 23.67 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.598 1.159 . . . . 0.0 109.79 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.24 2.82 74.52 Favored Glycine 0 C--O 1.243 0.702 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.811 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 18.57 66.19 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -108.54 144.42 36.24 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.988 0.423 . . . . 0.0 110.835 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -90.4 -7.41 53.27 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.098 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -114.55 -166.69 1.13 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.841 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 60.6 t -59.1 119.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 122.888 0.475 . . . . 0.0 110.919 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -99.76 130.02 45.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.69 110.24 17.62 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 124.888 1.275 . . . . 0.0 107.584 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.43 118.44 21.31 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.925 0.393 . . . . 0.0 111.902 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.5 mt -101.64 166.42 10.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.87 -45.94 87.18 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.479 0.657 . . . . 0.0 110.185 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.93 108.39 25.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.54 -145.75 28.05 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.996 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -162.61 171.85 16.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.148 0.979 . . . . 0.0 108.383 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -135.06 127.22 29.94 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.7 m -109.45 127.67 54.58 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.132 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 4.2 mp . . . . . 0 C--N 1.299 -1.616 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 . . . . . 0 CA--C 1.505 -0.756 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -63.91 -31.82 73.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.709 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.07 -29.47 70.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.46 -29.4 70.69 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.086 0.47 . . . . 0.0 112.12 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.47 107.91 19.08 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 57.92 34.46 24.34 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.95 35.4 21.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.467 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 69.27 10.33 62.42 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.798 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.86 85.7 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.0 m -92.93 134.87 34.67 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -81.31 -23.92 37.52 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -100.07 -170.13 1.83 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.732 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.7 130.69 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.9 t -88.58 143.69 26.79 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -126.24 113.23 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.22 129.82 35.55 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.204 0.526 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.3 mt -107.99 163.92 12.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -68.63 -45.33 72.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -105.47 87.82 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.106 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.33 -138.37 13.82 Favored Glycine 0 C--O 1.259 1.665 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.246 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -170.03 177.07 4.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.6 159.99 36.07 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.63 137.2 42.81 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.311 -1.08 0 CA-C-O 120.731 0.3 . . . . 0.0 110.563 -179.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 48.6 t-20 . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -65.39 -26.95 68.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.251 0.548 . . . . 0.0 111.275 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 71.0 m -72.11 -17.28 61.99 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.089 -176.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 51.4 mt -63.57 -35.83 81.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -106.89 118.35 36.46 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.72 17.68 10.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.808 1.243 . . . . 0.0 111.334 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.2 t30 57.65 37.41 27.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.321 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.77 -1.18 54.67 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.29 60.92 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.9 m -107.04 145.53 32.25 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.313 0.578 . . . . 0.0 111.107 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.38 -23.25 26.22 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -92.91 -171.72 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.396 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.64 130.87 26.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 122.525 0.33 . . . . 0.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.0 t -113.75 138.54 50.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -129.44 127.88 41.82 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.127 0.489 . . . . 0.0 110.031 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -74.83 131.43 40.76 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.122 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.477 HD21 ' OE2' ' A' ' 24' ' ' GLU . 87.7 mt -110.87 164.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -67.11 -36.27 81.57 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.683 0.754 . . . . 0.0 110.046 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.1 116.19 51.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -146.3 38.86 Favored Glycine 0 C--O 1.268 2.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.343 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -162.45 170.95 17.88 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' OE2' HD21 ' A' ' 19' ' ' LEU . 17.1 pt-20 -133.72 148.22 51.41 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -117.52 121.35 40.74 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.86 -175.181 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 121.542 0.687 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -67.46 -29.11 68.48 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 89.5 m -70.96 -24.4 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.47 -29.14 66.74 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.155 0.503 . . . . 0.0 111.649 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -89.99 108.95 20.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.644 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 58.34 25.95 13.43 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.829 0.852 . . . . 0.0 112.799 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 64.7 t30 61.59 35.43 17.26 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 122.375 1.083 . . . . 0.0 109.19 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 75.48 6.98 82.3 Favored Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.362 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 -1.58 88.78 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.03 145.03 24.95 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.292 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.18 -13.39 35.66 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.992 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -105.82 -168.52 1.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.15 119.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 122.544 0.338 . . . . 0.0 111.019 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.1 t -100.3 122.55 43.27 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -109.06 102.69 11.65 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.14 112.46 6.52 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.907 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.77 166.25 14.76 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.66 -54.05 50.9 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 120.492 1.496 . . . . 0.0 108.981 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tp -111.24 118.66 57.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.03 -160.51 35.21 Favored Glycine 0 C--O 1.272 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -161.22 164.3 30.5 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.71 144.32 48.85 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.9 m -130.79 123.74 29.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.583 0.706 . . . . 0.0 110.978 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--N 1.296 -1.752 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.924 -176.157 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.41 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 46.7 t-20 . . . . . 0 CA--C 1.508 -0.64 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -70.54 -32.44 69.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.305 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.06 -22.7 64.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.988 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 31.8 mt -61.1 -29.02 69.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.174 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -110.82 114.54 27.96 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.46 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 60.26 26.91 16.4 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.0 0.92 . . . . 0.0 112.162 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.61 33.63 20.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.285 1.04 . . . . 0.0 109.155 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.54 -0.26 56.17 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.379 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 1.17 77.57 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.37 132.58 33.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -85.43 -16.52 39.46 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -97.35 -166.4 1.39 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.3 144.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 118.735 0.698 . . . . 0.0 109.881 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -105.91 134.67 48.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -117.11 109.26 16.73 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.95 105.23 12.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.504 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.1 mt -84.48 170.03 13.91 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -58.04 -55.75 30.88 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-N 119.571 1.078 . . . . 0.0 109.539 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.6 pp -109.32 130.25 62.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.44 -149.98 51.01 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.676 -172.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -174.14 176.47 2.51 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.7 151.57 45.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -99.33 129.42 45.54 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 121.061 0.458 . . . . 0.0 110.193 -178.183 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.564 HD22 ' HG ' ' A' ' 6' ' ' LEU . 6.2 t30 . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -55.28 -31.25 61.43 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.355 1.062 . . . . 0.0 112.047 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HB2' ' ND2' ' A' ' 3' ' ' ASN . 55.6 m -61.57 -26.58 68.05 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.017 0.927 . . . . 0.0 111.878 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.564 ' HG ' HD22 ' A' ' 3' ' ' ASN . 42.1 mt -65.36 -25.75 67.72 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.093 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.93 96.77 7.48 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.6 37.06 28.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.305 1.042 . . . . 0.0 111.924 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 61.93 28.96 17.66 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.246 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.13 1.15 67.8 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.669 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.84 24.94 65.76 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.34 144.33 25.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -77.67 -26.33 50.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -120.34 -166.64 1.34 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.488 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.04 131.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.402 0.62 . . . . 0.0 111.993 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.28 145.92 25.6 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.214 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -125.82 124.07 40.13 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -81.65 128.51 34.02 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.321 0.581 . . . . 0.0 112.537 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.6 mt -112.22 162.12 15.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.15 -22.62 48.48 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.896 0.855 . . . . 0.0 109.45 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.97 38.02 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 122.639 1.209 . . . . 0.0 112.292 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.48 -131.15 6.25 Favored Glycine 0 C--N 1.271 -3.038 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.025 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.0 176.77 11.89 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.57 146.0 37.48 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.3 m -108.51 119.03 38.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.018 -176.047 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 . . . . . 0 C--O 1.244 0.764 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -68.68 -27.85 66.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.071 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.0 m -67.73 -26.55 66.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.809 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.38 -28.24 69.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.661 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.87 113.89 27.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.534 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.63 23.2 13.8 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.649 1.214 . . . . 0.0 110.224 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 8.5 t30 57.81 35.13 25.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.901 -1.499 . . . . 0.0 108.859 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 -12.96 30.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.308 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.77 6.98 59.14 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.3 m -95.63 126.31 40.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -74.11 -16.53 61.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 109.517 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -113.19 -166.25 1.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.64 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.52 130.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.06 0.457 . . . . 0.0 110.902 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.77 135.82 40.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 50.7 t30 -116.31 101.45 8.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.3 116.22 15.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.714 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.03 166.84 10.2 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.69 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.632 0.73 . . . . 0.0 110.069 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.47 134.36 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -148.45 50.56 Favored Glycine 0 C--O 1.269 2.327 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.285 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -175.64 166.34 3.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 17' ' ' ASN . 16.8 pt-20 -132.29 151.79 51.68 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.49 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -100.09 124.36 45.38 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 121.137 0.494 . . . . 0.0 110.096 -178.127 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.9 t30 . . . . . 0 CA--C 1.508 -0.644 0 CA-C-O 121.302 0.572 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -73.21 -21.36 60.67 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.524 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 72.9 m -73.4 -23.05 60.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 3' ' ' ASN . 4.1 pp -69.53 -29.38 66.97 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.909 1.337 . . . . 0.0 110.328 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 6' ' ' LEU . 19.9 t70 -88.87 97.5 11.21 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.133 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.58 32.29 18.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.403 1.081 . . . . 0.0 113.192 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 11.2 t30 62.7 32.26 16.25 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 124.434 1.094 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.36 3.57 66.39 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.852 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 5.51 89.77 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.3 m -86.91 132.47 33.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -78.52 -18.52 54.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.459 0.647 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -106.97 -166.52 1.17 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.693 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 62.5 t -59.59 140.65 17.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 120.788 0.328 . . . . 0.0 110.386 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.37 140.59 41.44 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.99 102.28 6.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.63 136.66 56.61 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.388 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.65 167.05 13.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -55.54 -48.31 74.91 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.0 pt -114.2 129.66 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.28 -139.82 48.41 Favored Glycine 0 C--O 1.266 2.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.101 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -169.64 178.82 3.98 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -142.41 147.7 36.61 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.2 m -91.84 141.73 28.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 83.7 mt . . . . . 0 C--N 1.306 -1.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 . . . . . 0 CA--C 1.497 -1.077 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -68.06 -21.56 64.98 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.698 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 84.4 m -76.59 -27.69 55.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.5 mt -67.77 -28.74 67.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.642 0.734 . . . . 0.0 110.602 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.01 103.02 15.66 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.476 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.46 23.6 13.21 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 124.44 1.096 . . . . 0.0 111.027 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.0 t30 60.39 36.68 20.34 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.642 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 5.32 71.7 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.087 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.81 13.7 71.73 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 78.6 m -109.84 144.33 38.45 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.955 0.883 . . . . 0.0 112.442 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.1 m -86.05 -22.85 27.0 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.792 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.5 176.74 7.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.77 132.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.458 0.474 . . . . 0.0 110.4 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -104.15 126.23 51.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -102.02 115.32 30.3 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.66 104.1 11.83 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.884 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 52.7 mt -77.41 160.55 28.66 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -58.95 -54.14 50.53 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.8 pt -104.69 134.18 46.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -153.24 46.49 Favored Glycine 0 C--O 1.278 2.868 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.463 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 36.0 p90 -158.88 173.47 16.47 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -143.31 113.73 7.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.812 0.445 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.29 136.6 32.87 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.693 -0.629 . . . . 0.0 110.531 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.393 -176.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.64 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t-20 . . . . . 0 CA--C 1.513 -0.472 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.487 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 23.5 mp0 -50.78 -37.42 42.23 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.071 0.548 . . . . 0.0 112.368 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.92 -23.82 55.08 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.983 0.913 . . . . 0.0 113.253 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 56.4 mt -65.16 -38.28 90.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.442 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.7 102.74 14.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.681 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 58.93 34.08 23.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.048 0.939 . . . . 0.0 112.004 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.2 29.32 17.43 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 -6.88 55.34 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.292 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.04 6.56 56.88 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.7 m -90.28 138.85 31.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -90.11 -21.28 22.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.815 0.817 . . . . 0.0 109.051 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -103.18 -166.19 1.24 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.55 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.22 133.45 25.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.198 0.523 . . . . 0.0 111.256 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -93.44 142.7 27.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.34 105.1 8.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.13 122.92 30.83 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.026 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.0 mt -106.2 166.42 10.53 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.026 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -63.41 -40.41 97.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -109.71 126.38 66.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.15 -136.9 47.9 Favored Glycine 0 C--O 1.271 2.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.307 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 7.4 p90 -175.76 -178.53 1.08 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.19 164.65 38.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.5 m -108.5 130.12 55.27 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.298 -1.642 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.66 -15.02 55.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.423 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 93.3 m -80.86 -23.91 38.75 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 7' ' ' ASP . 3.8 pp -73.22 -30.32 63.41 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 123.101 1.429 . . . . 0.0 109.706 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 6' ' ' LEU . 28.4 t70 -88.54 103.96 16.38 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.554 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.51 24.64 14.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.364 1.078 . . . . 0.0 110.691 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 5.6 t30 57.95 36.49 26.23 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.602 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 72.66 0.73 50.64 Favored Glycine 0 C--O 1.244 0.721 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.91 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.36 89.45 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.7 m -100.53 136.94 39.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.7 p -76.38 -14.67 60.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.045 0.538 . . . . 0.0 112.01 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -111.99 -166.86 1.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.063 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.13 128.69 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 0.0 111.846 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.3 t -111.3 132.06 54.67 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -124.23 112.25 16.81 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -68.64 129.7 40.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.635 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -112.39 164.55 13.13 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.676 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.7 -46.44 90.37 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.688 0.618 . . . . 0.0 110.145 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.7 pp -110.29 123.14 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.63 -142.62 42.51 Favored Glycine 0 C--O 1.271 2.446 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.694 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -167.57 163.27 14.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.18 153.15 39.15 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -125.81 125.34 42.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.591 0.71 . . . . 0.0 109.962 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 C--N 1.299 -1.6 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.358 -177.195 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 13.4 mp0 -70.85 -37.01 73.09 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.865 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.7 m -67.96 -28.12 67.19 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 124.023 0.929 . . . . 0.0 112.223 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -23.16 61.84 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -99.07 89.19 4.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.764 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.98 44.38 28.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.368 1.067 . . . . 0.0 113.139 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 59.99 28.69 18.25 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.888 1.275 . . . . 0.0 110.679 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.32 0.44 53.14 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.034 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.69 84.89 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.9 m -85.65 136.45 33.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.5 t -77.27 -16.44 58.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.959 0.409 . . . . 0.0 110.487 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -123.38 -164.37 1.21 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.734 0.814 . . . . 0.0 108.852 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.3 136.54 17.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 110.12 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.3 t -102.9 145.61 29.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -129.34 104.54 7.56 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.76 118.54 22.38 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.32 166.22 10.57 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.18 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.47 -32.51 48.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.282 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.6 tp -101.34 84.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.79 -132.77 11.49 Favored Glycine 0 C--O 1.253 1.3 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.631 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 22.9 p90 -156.79 177.98 10.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 136.24 21.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 123.068 0.547 . . . . 0.0 110.158 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.88 128.22 48.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 121.345 0.593 . . . . 0.0 109.946 -179.163 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 56.2 t-20 . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.34 -23.96 34.81 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.225 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 82.5 m -81.58 -19.31 42.22 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.721 0.772 . . . . 0.0 111.061 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 5.0 tt -62.26 -41.67 98.65 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.58 106.89 18.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.407 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 61.26 24.5 14.6 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.278 1.031 . . . . 0.0 112.71 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 65.7 t30 56.04 32.58 20.24 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.86 1.264 . . . . 0.0 109.73 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.12 -4.08 19.27 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.251 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.34 19.2 42.73 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.9 m -102.74 135.0 45.21 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -88.58 -14.48 37.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.683 0.754 . . . . 0.0 110.174 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -107.98 -166.67 1.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.64 137.88 23.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -107.33 144.91 33.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.462 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 42.3 t30 -118.17 113.9 22.24 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.43 94.26 4.87 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.662 0.744 . . . . 0.0 111.128 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 58.3 mt -71.07 165.49 23.4 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.22 -53.89 48.74 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.3 tp -96.02 113.75 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.331 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.71 -139.67 30.48 Favored Glycine 0 C--O 1.266 2.126 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.392 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 41.7 p90 -167.69 -176.43 3.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.3 pt-20 -147.31 142.16 26.85 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -89.06 123.87 33.76 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 121.341 0.591 . . . . 0.0 109.523 -177.605 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.25 -32.98 38.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.957 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.1 m -75.06 -21.59 58.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.31 -16.7 34.32 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 121.366 0.603 . . . . 0.0 111.048 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -98.16 92.53 5.79 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.144 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.3 26.6 12.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.97 1.367 . . . . 0.0 110.396 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.7 t30 57.6 37.51 27.53 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.822 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.8 7.02 60.89 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 13.16 82.28 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.9 m -106.43 148.94 27.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.127 0.489 . . . . 0.0 111.601 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.59 -19.23 23.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.595 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -92.37 -172.17 3.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.921 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.9 125.76 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.7 t -98.7 143.16 29.37 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.83 105.65 10.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.54 114.85 17.82 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.96 0.41 . . . . 0.0 111.602 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.23 165.78 12.64 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -72.13 -39.63 68.67 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 tp -117.65 87.5 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.379 1.085 . . . . 0.0 108.933 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.56 -148.55 17.09 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.63 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.9 p90 176.02 165.94 0.4 Allowed 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.93 168.68 19.68 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -119.95 128.89 54.0 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.513 -175.389 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 58.5 t-20 . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -69.22 -26.64 64.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 111.854 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 87.5 m -82.88 -17.35 44.11 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.592 0.71 . . . . 0.0 111.434 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.621 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 13.2 tp -71.29 -21.43 62.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -109.69 110.79 21.94 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.192 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 61.18 25.62 15.6 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.251 1.021 . . . . 0.0 113.129 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.1 t30 54.94 34.31 21.99 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.882 1.273 . . . . 0.0 109.92 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 7.38 67.07 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.604 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 4.44 78.89 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.7 m -105.62 148.56 27.2 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -90.39 -20.65 22.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.386 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.91 -167.17 1.55 Allowed 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.079 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.43 113.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.344 0.593 . . . . 0.0 110.439 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.9 t -92.09 135.8 33.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -117.06 112.69 21.26 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.141 0.496 . . . . 0.0 110.168 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.15 110.46 6.63 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.631 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 62.0 mt -85.67 178.87 7.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.51 -55.0 13.22 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.44 112.37 39.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.77 -166.3 27.56 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.02 -173.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.409 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 21.3 p90 -162.44 168.21 22.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -135.54 161.15 36.3 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -124.43 129.27 50.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.058 -178.006 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.62 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.6 t-20 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -54.46 -33.23 59.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 56.7 m -63.14 -21.79 66.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.548 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.62 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 44.1 mt -64.0 -34.86 78.97 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.05 98.28 9.93 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 34.81 22.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.295 1.038 . . . . 0.0 112.352 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.5 t30 57.76 37.04 27.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 0.0 109.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.18 84.32 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.68 65.65 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.67 135.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.092 0.472 . . . . 0.0 111.119 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 m -89.15 -10.38 47.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.3 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -108.95 -168.16 1.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.96 117.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.165 0.507 . . . . 0.0 111.313 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -84.18 139.18 32.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -125.8 92.06 3.52 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.754 0.788 . . . . 0.0 108.976 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.19 119.83 19.85 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.56 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.05 170.0 8.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.92 -43.56 87.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 118.677 0.671 . . . . 0.0 109.425 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.55 110.11 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.81 -138.51 35.37 Favored Glycine 0 C--O 1.263 1.967 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.483 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -173.83 -176.74 1.26 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.91 169.96 23.6 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -131.29 149.48 52.54 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.52 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.668 -175.049 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.585 ' ND2' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -53.89 -38.52 64.88 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.931 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 79.0 m -61.01 -21.77 63.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' ND2' ' A' ' 3' ' ' ASN . 2.9 mm? -81.86 -17.35 47.65 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.94 107.05 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.818 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 60.35 28.95 18.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.821 0.819 . . . . 0.0 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 6.3 t30 53.27 41.19 32.14 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.823 1.649 . . . . 0.0 110.801 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.8 80.03 Favored Glycine 0 CA--C 1.504 -0.639 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.346 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.23 70.45 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.5 m -117.36 129.82 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -75.81 -29.15 58.59 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.863 0.363 . . . . 0.0 110.212 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.403 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 3.0 p80 -85.19 -171.15 3.48 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.413 174.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 14' ' ' HIS . 57.6 t -56.86 134.68 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 123.586 0.554 . . . . 0.0 111.838 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.41 148.72 35.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -130.75 102.98 6.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.83 118.96 19.18 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.549 0.69 . . . . 0.0 112.143 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.36 166.55 10.36 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -67.37 -47.61 69.86 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.12 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.93 -141.58 31.91 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.137 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.34 178.75 9.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.23 151.25 40.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.4 m -126.67 134.06 50.8 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.274 -173.409 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.449 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.01 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.45 -37.56 56.76 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.597 0.759 . . . . 0.0 110.175 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.8 m -58.4 -25.69 62.4 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 63.6 mt -58.79 -39.25 80.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.41 125.32 53.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.748 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.35 19.46 11.7 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.572 1.149 . . . . 0.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.2 t30 58.4 33.05 22.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.156 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.31 6.61 61.87 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.343 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.93 78.78 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.8 m -85.4 128.75 34.82 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -79.41 -21.94 44.93 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.512 0.672 . . . . 0.0 109.31 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -103.79 -167.48 1.38 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.928 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.75 131.24 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 t -98.02 137.6 36.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 46.9 t30 -124.92 114.69 19.51 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.13 133.68 34.73 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.69 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.93 166.25 12.19 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -55.41 -49.43 72.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.801 0.81 . . . . 0.0 109.368 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.88 131.41 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.79 -138.41 41.76 Favored Glycine 0 C--O 1.263 1.962 0 O-C-N 123.742 0.651 . . . . 0.0 112.671 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -175.23 176.64 2.02 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 17' ' ' ASN . 22.3 pt-20 -144.39 138.52 27.82 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.983 0.42 . . . . 0.0 110.796 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.07 125.43 35.86 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.9 mt . . . . . 0 C--N 1.311 -1.097 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.606 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.368 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.6 t -163.13 140.54 7.69 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -93.9 109.88 21.57 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.571 0.224 . . . . 0.0 110.735 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -73.25 -29.62 62.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.278 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.4 m -63.06 -26.64 68.93 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.4 0.68 . . . . 0.0 111.223 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 71.7 mt -62.03 -35.3 78.16 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.488 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -107.12 106.85 17.54 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.058 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 62.84 26.79 15.75 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.05 0.94 . . . . 0.0 112.256 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 58.56 32.16 21.84 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.514 1.126 . . . . 0.0 109.805 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.05 -1.48 40.29 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 113.156 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.46 5.1 69.86 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.41 141.26 38.46 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.066 0.46 . . . . 0.0 110.226 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -83.21 -10.2 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.545 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -134.1 -167.5 1.97 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.4 127.26 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.428 0.558 . . . . 0.0 111.614 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -85.33 149.16 25.65 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.25 110.35 11.05 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -76.14 124.3 27.22 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.24 0.543 . . . . 0.0 111.216 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 73.5 mt -100.72 167.6 10.21 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -66.66 -46.32 76.09 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.1 tp -109.78 109.55 28.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.935 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.94 -145.33 25.76 Favored Glycine 0 C--O 1.257 1.56 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 30.6 p90 -159.25 175.06 13.87 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' HB2' HD11 ' A' ' 19' ' ' LEU . 39.1 tt0 -140.18 147.24 39.83 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 123.537 0.523 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.8 m -111.49 128.19 55.93 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.94 -99.88 0.43 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.998 0 O-C-N 122.022 -0.424 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.879 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 t -116.97 96.9 5.67 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.986 0.898 . . . . 0.0 112.043 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -95.61 108.55 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -73.83 -27.96 61.37 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.749 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.7 m -68.38 -21.16 64.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.091 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 tt -61.74 -34.51 75.96 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -95.47 101.19 12.89 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.963 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 53.88 38.04 27.84 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.797 1.239 . . . . 0.0 113.474 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.4 t30 62.73 26.2 15.5 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 124.782 1.233 . . . . 0.0 110.144 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.07 3.71 53.1 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.267 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.17 13.72 80.35 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.14 137.56 33.47 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.4 p -85.4 -5.65 59.28 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.941 0.876 . . . . 0.0 110.07 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -129.18 -166.42 1.65 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.05 129.27 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -92.32 145.29 24.59 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -125.16 108.51 11.85 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.5 112.7 12.09 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.411 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 69.5 mt -96.42 167.65 11.04 Favored 'General case' 0 C--O 1.254 1.294 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -57.95 -50.69 72.51 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.983 0.802 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.22 132.31 63.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.47 -145.34 49.63 Favored Glycine 0 C--O 1.272 2.481 0 C-N-CA 120.496 -0.859 . . . . 0.0 110.974 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 9.4 p90 -169.54 172.27 7.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -141.78 163.97 31.46 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.9 m -110.11 135.31 51.11 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.0 mt -116.47 -90.59 0.55 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.143 0 O-C-N 122.3 -0.25 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -94.22 140.91 29.17 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -99.09 89.88 4.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 mp0 -61.16 -36.15 79.03 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.657 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.1 m -65.1 -27.39 68.72 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -174.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.13 -30.42 70.42 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.314 0.578 . . . . 0.0 111.235 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -96.5 102.89 14.75 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 61.34 27.32 16.99 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.383 0.673 . . . . 0.0 111.801 175.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.6 t30 58.61 34.2 23.67 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.598 1.159 . . . . 0.0 109.79 -177.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.24 2.82 74.52 Favored Glycine 0 C--O 1.243 0.702 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.811 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 18.57 66.19 Favored Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 75.1 m -108.54 144.42 36.24 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 120.988 0.423 . . . . 0.0 110.835 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -90.4 -7.41 53.27 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.098 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -114.55 -166.69 1.13 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.841 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 60.6 t -59.1 119.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 122.888 0.475 . . . . 0.0 110.919 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.3 t -99.76 130.02 45.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.69 110.24 17.62 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 124.888 1.275 . . . . 0.0 107.584 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.43 118.44 21.31 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.925 0.393 . . . . 0.0 111.902 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.5 mt -101.64 166.42 10.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.87 -45.94 87.18 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.479 0.657 . . . . 0.0 110.185 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.9 mm -109.93 108.39 25.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.54 -145.75 28.05 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.996 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -162.61 171.85 16.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.148 0.979 . . . . 0.0 108.383 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -135.06 127.22 29.94 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.7 m -109.45 127.67 54.58 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.132 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 4.2 mp -104.52 96.9 6.92 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 116.56 -0.291 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.462 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.1 m -65.77 136.82 56.73 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.449 0.7 . . . . 0.0 111.327 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -104.19 95.96 6.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -63.91 -31.82 73.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.709 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.07 -29.47 70.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.9 mt -63.46 -29.4 70.69 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.086 0.47 . . . . 0.0 112.12 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -104.47 107.91 19.08 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.897 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 57.92 34.46 24.34 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.95 35.4 21.63 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.467 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 69.27 10.33 62.42 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.798 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.13 10.86 85.7 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.0 m -92.93 134.87 34.67 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 p -81.31 -23.92 37.52 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -100.07 -170.13 1.83 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.732 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.7 130.69 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 47.9 t -88.58 143.69 26.79 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -126.24 113.23 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -78.22 129.82 35.55 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.204 0.526 . . . . 0.0 110.387 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 72.3 mt -107.99 163.92 12.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -68.63 -45.33 72.14 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 tp -105.47 87.82 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.106 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.33 -138.37 13.82 Favored Glycine 0 C--O 1.259 1.665 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.246 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -170.03 177.07 4.44 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -158.6 159.99 36.07 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.63 137.2 42.81 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.1 mt -119.17 -89.63 0.59 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 120.731 0.3 . . . . 0.0 110.563 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.035 0 O-C-N 122.185 -0.322 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.177 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.5 m -94.25 121.72 36.04 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.485 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 48.6 t-20 -94.62 98.15 10.61 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -65.39 -26.95 68.22 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.251 0.548 . . . . 0.0 111.275 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 71.0 m -72.11 -17.28 61.99 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.089 -176.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 51.4 mt -63.57 -35.83 81.8 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -106.89 118.35 36.46 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.663 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.72 17.68 10.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.808 1.243 . . . . 0.0 111.334 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.2 t30 57.65 37.41 27.39 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.321 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.77 -1.18 54.67 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.302 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.03 9.29 60.92 Favored Glycine 0 N--CA 1.434 -1.493 0 N-CA-C 110.854 -0.899 . . . . 0.0 110.854 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.9 m -107.04 145.53 32.25 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.313 0.578 . . . . 0.0 111.107 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 t -86.38 -23.25 26.22 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.603 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -92.91 -171.72 2.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.396 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.64 130.87 26.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 122.525 0.33 . . . . 0.0 110.59 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.0 t -113.75 138.54 50.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -129.44 127.88 41.82 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.127 0.489 . . . . 0.0 110.031 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -74.83 131.43 40.76 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.122 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.477 HD21 ' OE2' ' A' ' 24' ' ' GLU . 87.7 mt -110.87 164.94 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -67.11 -36.27 81.57 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.683 0.754 . . . . 0.0 110.046 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.1 116.19 51.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.39 -146.3 38.86 Favored Glycine 0 C--O 1.268 2.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.343 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -162.45 170.95 17.88 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' OE2' HD21 ' A' ' 19' ' ' LEU . 17.1 pt-20 -133.72 148.22 51.41 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.7 m -117.52 121.35 40.74 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.8 mt -94.71 92.86 7.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.86 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 116.392 -0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.92 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 m -89.44 82.8 6.38 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -108.73 93.87 4.75 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.542 0.687 . . . . 0.0 109.945 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.7 mp0 -67.46 -29.11 68.48 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.413 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 89.5 m -70.96 -24.4 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.5 mt -69.47 -29.14 66.74 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.155 0.503 . . . . 0.0 111.649 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -89.99 108.95 20.03 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.644 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 58.34 25.95 13.43 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.829 0.852 . . . . 0.0 112.799 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 64.7 t30 61.59 35.43 17.26 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 122.375 1.083 . . . . 0.0 109.19 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 75.48 6.98 82.3 Favored Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.362 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 -1.58 88.78 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.03 145.03 24.95 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.292 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.18 -13.39 35.66 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.992 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -105.82 -168.52 1.46 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.15 119.08 3.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 122.544 0.338 . . . . 0.0 111.019 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.1 t -100.3 122.55 43.27 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -109.06 102.69 11.65 Favored 'General case' 0 C--N 1.269 -2.932 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.14 112.46 6.52 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.907 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.8 mt -87.77 166.25 14.76 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -59.66 -54.05 50.9 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-N 120.492 1.496 . . . . 0.0 108.981 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 tp -111.24 118.66 57.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.03 -160.51 35.21 Favored Glycine 0 C--O 1.272 2.472 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -161.22 164.3 30.5 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -121.71 144.32 48.85 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.9 m -130.79 123.74 29.82 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.583 0.706 . . . . 0.0 110.978 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -114.68 97.95 6.58 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.924 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 CA-C-N 116.556 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.756 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -88.21 107.07 18.6 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 121.479 0.657 . . . . 0.0 111.272 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.41 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 46.7 t-20 -107.22 102.35 11.67 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -70.54 -32.44 69.88 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.305 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.06 -22.7 64.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.988 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 31.8 mt -61.1 -29.02 69.5 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.174 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -110.82 114.54 27.96 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.46 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 60.26 26.91 16.4 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.0 0.92 . . . . 0.0 112.162 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.61 33.63 20.34 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.285 1.04 . . . . 0.0 109.155 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.54 -0.26 56.17 Favored Glycine 0 C--O 1.217 -0.936 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.379 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.74 1.17 77.57 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.5 m -86.37 132.58 33.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 m -85.43 -16.52 39.46 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -97.35 -166.4 1.39 Allowed 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.3 144.55 14.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 118.735 0.698 . . . . 0.0 109.881 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -105.91 134.67 48.65 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -117.11 109.26 16.73 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -81.95 105.23 12.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.504 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.1 mt -84.48 170.03 13.91 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -58.04 -55.75 30.88 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-N 119.571 1.078 . . . . 0.0 109.539 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.6 pp -109.32 130.25 62.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.44 -149.98 51.01 Favored Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.676 -172.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -174.14 176.47 2.51 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.7 151.57 45.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -99.33 129.42 45.54 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.5 mt -107.06 96.15 6.22 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.061 0.458 . . . . 0.0 110.193 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-N 116.491 -0.322 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.209 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t -59.37 121.68 12.05 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 121.994 0.902 . . . . 0.0 109.764 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.564 HD22 ' HG ' ' A' ' 6' ' ' LEU . 6.2 t30 -103.29 95.12 5.89 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.227 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -55.28 -31.25 61.43 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.355 1.062 . . . . 0.0 112.047 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HB2' ' ND2' ' A' ' 3' ' ' ASN . 55.6 m -61.57 -26.58 68.05 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.017 0.927 . . . . 0.0 111.878 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.564 ' HG ' HD22 ' A' ' 3' ' ' ASN . 42.1 mt -65.36 -25.75 67.72 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.093 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.93 96.77 7.48 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.911 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.6 37.06 28.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.305 1.042 . . . . 0.0 111.924 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 61.93 28.96 17.66 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.246 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.13 1.15 67.8 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.669 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.84 24.94 65.76 Favored Glycine 0 N--CA 1.436 -1.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 67.7 m -95.34 144.33 25.98 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 t -77.67 -26.33 50.25 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -120.34 -166.64 1.34 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.488 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.04 131.85 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.402 0.62 . . . . 0.0 111.993 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.28 145.92 25.6 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.214 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -125.82 124.07 40.13 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -81.65 128.51 34.02 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.321 0.581 . . . . 0.0 112.537 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.6 mt -112.22 162.12 15.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.15 -22.62 48.48 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.896 0.855 . . . . 0.0 109.45 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 pp -112.97 38.02 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 122.639 1.209 . . . . 0.0 112.292 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.48 -131.15 6.25 Favored Glycine 0 C--N 1.271 -3.038 0 CA-C-N 113.785 -1.552 . . . . 0.0 111.025 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.0 176.77 11.89 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -140.57 146.0 37.48 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.3 m -108.51 119.03 38.32 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.54 79.52 6.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.244 0.545 . . . . 0.0 110.018 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.557 0 CA-C-N 116.053 -0.521 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.716 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.5 t -84.87 109.87 18.43 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 122.161 0.981 . . . . 0.0 112.69 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -100.34 100.61 11.43 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -68.68 -27.85 66.35 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.071 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 78.0 m -67.73 -26.55 66.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.809 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.38 -28.24 69.13 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.661 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.87 113.89 27.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.534 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 62.63 23.2 13.8 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.649 1.214 . . . . 0.0 110.224 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 8.5 t30 57.81 35.13 25.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.901 -1.499 . . . . 0.0 108.859 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.37 -12.96 30.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.308 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.77 6.98 59.14 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -172.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.3 m -95.63 126.31 40.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 m -74.11 -16.53 61.01 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.986 0.898 . . . . 0.0 109.517 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -113.19 -166.25 1.07 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.64 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.52 130.97 22.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.06 0.457 . . . . 0.0 110.902 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.77 135.82 40.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 24' ' ' GLU . 50.7 t30 -116.31 101.45 8.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.3 116.22 15.79 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.714 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.5 mt -103.03 166.84 10.2 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.69 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -56.93 -45.61 82.61 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.632 0.73 . . . . 0.0 110.069 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.47 134.36 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -148.45 50.56 Favored Glycine 0 C--O 1.269 2.327 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.285 -175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -175.64 166.34 3.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 17' ' ' ASN . 16.8 pt-20 -132.29 151.79 51.68 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.49 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -100.09 124.36 45.38 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.0 mt -91.6 93.06 8.76 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.137 0.494 . . . . 0.0 110.096 -178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.461 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 m -79.97 89.29 5.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.615 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 27.9 t30 -90.97 107.79 19.43 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.302 0.572 . . . . 0.0 110.782 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -73.21 -21.36 60.67 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.524 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 72.9 m -73.4 -23.05 60.1 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 3' ' ' ASN . 4.1 pp -69.53 -29.38 66.97 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.909 1.337 . . . . 0.0 110.328 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' N ' HD12 ' A' ' 6' ' ' LEU . 19.9 t70 -88.87 97.5 11.21 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.133 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.58 32.29 18.88 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.403 1.081 . . . . 0.0 113.192 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 11.2 t30 62.7 32.26 16.25 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 124.434 1.094 . . . . 0.0 109.806 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.36 3.57 66.39 Favored Glycine 0 C--O 1.22 -0.779 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.852 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 5.51 89.77 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.3 m -86.91 132.47 33.8 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 m -78.52 -18.52 54.61 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.459 0.647 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -106.97 -166.52 1.17 Allowed 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.693 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 26' ' ' LEU . 62.5 t -59.59 140.65 17.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 120.788 0.328 . . . . 0.0 110.386 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.7 t -108.37 140.59 41.44 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.99 102.28 6.68 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.63 136.66 56.61 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.388 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 69.0 mt -121.65 167.05 13.36 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -55.54 -48.31 74.91 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.0 pt -114.2 129.66 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.28 -139.82 48.41 Favored Glycine 0 C--O 1.266 2.138 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.101 -174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -169.64 178.82 3.98 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -142.41 147.7 36.61 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.2 m -91.84 141.73 28.35 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 15' ' ' VAL . 83.7 mt -110.75 96.42 6.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.316 0 CA-C-N 116.607 -0.27 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.179 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 2' ' ' THR . 19.3 m -106.56 28.72 7.56 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 123.009 1.385 . . . . 0.0 111.551 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -112.65 87.87 2.69 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mp0 -68.06 -21.56 64.98 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.698 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 84.4 m -76.59 -27.69 55.88 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.5 mt -67.77 -28.74 67.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.642 0.734 . . . . 0.0 110.602 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.01 103.02 15.66 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.476 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 60.46 23.6 13.21 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 124.44 1.096 . . . . 0.0 111.027 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.0 t30 60.39 36.68 20.34 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.642 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.31 5.32 71.7 Favored Glycine 0 C--O 1.239 0.424 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.087 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.81 13.7 71.73 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 78.6 m -109.84 144.33 38.45 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 121.955 0.883 . . . . 0.0 112.442 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.1 m -86.05 -22.85 27.0 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.792 173.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -88.5 176.74 7.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.77 132.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.458 0.474 . . . . 0.0 110.4 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -104.15 126.23 51.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -102.02 115.32 30.3 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.66 104.1 11.83 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.884 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 52.7 mt -77.41 160.55 28.66 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -58.95 -54.14 50.53 Favored 'General case' 0 C--O 1.247 0.94 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -178.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.8 pt -104.69 134.18 46.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -153.24 46.49 Favored Glycine 0 C--O 1.278 2.868 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.463 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 36.0 p90 -158.88 173.47 16.47 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -143.31 113.73 7.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.812 0.445 . . . . 0.0 110.625 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.5 m -87.29 136.6 32.87 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.693 -0.629 . . . . 0.0 110.531 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.41 -93.55 0.52 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.393 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.816 0 O-C-N 122.067 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.721 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 m -82.65 115.62 21.68 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.64 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t-20 -98.36 82.33 2.88 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.487 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 23.5 mp0 -50.78 -37.42 42.23 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.071 0.548 . . . . 0.0 112.368 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.92 -23.82 55.08 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 123.983 0.913 . . . . 0.0 113.253 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 56.4 mt -65.16 -38.28 90.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.442 176.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.7 102.74 14.57 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.681 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 58.93 34.08 23.42 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.048 0.939 . . . . 0.0 112.004 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 62.2 29.32 17.43 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.13 -6.88 55.34 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.292 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.04 6.56 56.88 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.7 m -90.28 138.85 31.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 p -90.11 -21.28 22.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.815 0.817 . . . . 0.0 109.051 175.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -103.18 -166.19 1.24 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.359 -1.291 . . . . 0.0 107.55 176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.22 133.45 25.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.198 0.523 . . . . 0.0 111.256 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -93.44 142.7 27.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -127.34 105.1 8.3 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -86.13 122.92 30.83 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.026 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 73.0 mt -106.2 166.42 10.53 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.026 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -63.41 -40.41 97.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 pt -109.71 126.38 66.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.15 -136.9 47.9 Favored Glycine 0 C--O 1.271 2.441 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.307 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 7.4 p90 -175.76 -178.53 1.08 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -155.19 164.65 38.53 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.5 m -108.5 130.12 55.27 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.71 93.54 4.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.434 0 CA-C-N 116.369 -0.378 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.725 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.8 m -77.45 130.55 37.18 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 122.87 0.468 . . . . 0.0 110.008 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -91.51 99.59 12.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.66 -15.02 55.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.423 -177.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 93.3 m -80.86 -23.91 38.75 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 7' ' ' ASP . 3.8 pp -73.22 -30.32 63.41 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 123.101 1.429 . . . . 0.0 109.706 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 6' ' ' LEU . 28.4 t70 -88.54 103.96 16.38 Favored 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 112.49 -2.141 . . . . 0.0 110.554 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.8 t30 60.51 24.64 14.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 122.364 1.078 . . . . 0.0 110.691 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 5.6 t30 57.95 36.49 26.23 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.602 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 16' ' ' CYS . . . 72.66 0.73 50.64 Favored Glycine 0 C--O 1.244 0.721 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.91 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.84 5.36 89.45 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 70.7 m -100.53 136.94 39.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.7 p -76.38 -14.67 60.06 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.045 0.538 . . . . 0.0 112.01 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -111.99 -166.86 1.12 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.063 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.13 128.69 17.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.081 0.467 . . . . 0.0 111.846 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' SG ' ' HA3' ' A' ' 10' ' ' GLY . 14.3 t -111.3 132.06 54.67 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -124.23 112.25 16.81 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -68.64 129.7 40.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.635 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.7 mt -112.39 164.55 13.13 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.676 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -60.7 -46.44 90.37 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.688 0.618 . . . . 0.0 110.145 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 21' ' ' ILE . 2.7 pp -110.29 123.14 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 170.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.63 -142.62 42.51 Favored Glycine 0 C--O 1.271 2.446 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.694 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -167.57 163.27 14.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -122.18 153.15 39.15 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.8 m -125.81 125.34 42.75 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 121.591 0.71 . . . . 0.0 109.962 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.2 mt -116.56 87.72 2.75 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.358 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.613 0 CA-C-N 116.066 -0.515 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.385 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.4 m -78.59 88.81 4.51 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.811 0.815 . . . . 0.0 108.803 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -89.26 109.97 20.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.226 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 13.4 mp0 -70.85 -37.01 73.09 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.865 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.7 m -67.96 -28.12 67.19 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 124.023 0.929 . . . . 0.0 112.223 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -23.16 61.84 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -99.07 89.19 4.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.764 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.98 44.38 28.35 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.368 1.067 . . . . 0.0 113.139 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t30 59.99 28.69 18.25 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.888 1.275 . . . . 0.0 110.679 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.32 0.44 53.14 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.034 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.65 10.69 84.89 Favored Glycine 0 N--CA 1.434 -1.474 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -173.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.9 m -85.65 136.45 33.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.5 t -77.27 -16.44 58.99 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.959 0.409 . . . . 0.0 110.487 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -123.38 -164.37 1.21 Allowed 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.734 0.814 . . . . 0.0 108.852 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.3 136.54 17.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.489 0.661 . . . . 0.0 110.12 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.3 t -102.9 145.61 29.55 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -129.34 104.54 7.56 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.76 118.54 22.38 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.4 mt -105.32 166.22 10.57 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.18 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.47 -32.51 48.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.282 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.6 tp -101.34 84.74 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.79 -132.77 11.49 Favored Glycine 0 C--O 1.253 1.3 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.631 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.518 ' CD1' ' HG2' ' A' ' 4' ' ' GLU . 22.9 p90 -156.79 177.98 10.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 136.24 21.5 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 123.068 0.547 . . . . 0.0 110.158 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.4 m -101.88 128.22 48.37 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.2 mt -103.06 77.68 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.345 0.593 . . . . 0.0 109.946 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 116.132 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.391 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -81.99 89.77 6.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 122.693 1.235 . . . . 0.0 109.256 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.42 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 56.2 t-20 -87.33 110.41 20.21 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.632 -177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -82.34 -23.96 34.81 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.225 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 82.5 m -81.58 -19.31 42.22 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.721 0.772 . . . . 0.0 111.061 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 5.0 tt -62.26 -41.67 98.65 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -93.58 106.89 18.82 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.407 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 61.26 24.5 14.6 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.278 1.031 . . . . 0.0 112.71 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 65.7 t30 56.04 32.58 20.24 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.86 1.264 . . . . 0.0 109.73 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.12 -4.08 19.27 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.251 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.34 19.2 42.73 Favored Glycine 0 N--CA 1.434 -1.469 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 33.9 m -102.74 135.0 45.21 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -88.58 -14.48 37.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.683 0.754 . . . . 0.0 110.174 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -107.98 -166.67 1.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 174.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.64 137.88 23.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.649 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -107.33 144.91 33.52 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.462 ' HB3' ' CG ' ' A' ' 24' ' ' GLU . 42.3 t30 -118.17 113.9 22.24 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -78.43 94.26 4.87 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.662 0.744 . . . . 0.0 111.128 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 58.3 mt -71.07 165.49 23.4 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 173.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -62.22 -53.89 48.74 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.3 tp -96.02 113.75 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.331 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.71 -139.67 30.48 Favored Glycine 0 C--O 1.266 2.126 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.392 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 41.7 p90 -167.69 -176.43 3.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' CG ' ' HB3' ' A' ' 17' ' ' ASN . 16.3 pt-20 -147.31 142.16 26.85 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.4 m -89.06 123.87 33.76 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.15 90.0 8.19 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.341 0.591 . . . . 0.0 109.523 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.766 0 CA-C-N 115.78 -0.646 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.31 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 t -132.81 114.88 14.61 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 121.744 0.783 . . . . 0.0 111.097 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -98.52 109.22 22.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.38 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.25 -32.98 38.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.957 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.1 m -75.06 -21.59 58.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.31 -16.7 34.32 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-O 121.366 0.603 . . . . 0.0 111.048 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -98.16 92.53 5.79 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.144 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 65.3 26.6 12.14 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.97 1.367 . . . . 0.0 110.396 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.7 t30 57.6 37.51 27.53 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.822 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.8 7.02 60.89 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.676 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 13.16 82.28 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 95.9 m -106.43 148.94 27.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.127 0.489 . . . . 0.0 111.601 -176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.9 p -90.59 -19.23 23.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.595 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -92.37 -172.17 3.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.921 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.9 125.76 28.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.7 t -98.7 143.16 29.37 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -121.83 105.65 10.56 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -78.54 114.85 17.82 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.96 0.41 . . . . 0.0 111.602 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.23 165.78 12.64 Favored 'General case' 0 C--O 1.255 1.37 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -72.13 -39.63 68.67 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 tp -117.65 87.5 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.379 1.085 . . . . 0.0 108.933 175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.56 -148.55 17.09 Favored Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.63 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.9 p90 176.02 165.94 0.4 Allowed 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.93 168.68 19.68 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 170.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -119.95 128.89 54.0 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.9 mt -100.06 -94.86 0.26 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.513 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.198 0 O-C-N 121.887 -0.508 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.96 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 t -152.1 92.59 1.73 Allowed 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.205 0.526 . . . . 0.0 111.152 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.621 ' CG ' ' HB2' ' A' ' 6' ' ' LEU . 58.5 t-20 -96.51 97.09 9.14 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 174.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -69.22 -26.64 64.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.054 0.454 . . . . 0.0 111.854 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 87.5 m -82.88 -17.35 44.11 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.592 0.71 . . . . 0.0 111.434 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.621 ' HB2' ' CG ' ' A' ' 3' ' ' ASN . 13.2 tp -71.29 -21.43 62.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.663 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -109.69 110.79 21.94 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.192 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 61.18 25.62 15.6 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.251 1.021 . . . . 0.0 113.129 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.1 t30 54.94 34.31 21.99 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.882 1.273 . . . . 0.0 109.92 -177.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.16 7.38 67.07 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.604 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.87 4.44 78.89 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 74.7 m -105.62 148.56 27.2 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -90.39 -20.65 22.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.386 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.91 -167.17 1.55 Allowed 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.079 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.43 113.14 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.344 0.593 . . . . 0.0 110.439 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.9 t -92.09 135.8 33.68 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -117.06 112.69 21.26 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.141 0.496 . . . . 0.0 110.168 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.15 110.46 6.63 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.631 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' HA ' ' A' ' 23' ' ' TYR . 62.0 mt -85.67 178.87 7.22 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.51 -55.0 13.22 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.24 -1.384 . . . . 0.0 109.31 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.44 112.37 39.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 N-CA-C 106.274 -1.751 . . . . 0.0 106.274 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.77 -166.3 27.56 Favored Glycine 0 N--CA 1.413 -2.834 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.02 -173.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' HA ' ' H ' ' A' ' 19' ' ' LEU . 21.3 p90 -162.44 168.21 22.39 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -135.54 161.15 36.3 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.2 m -124.43 129.27 50.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.75 89.32 6.13 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.058 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.294 0 CA-C-N 116.386 -0.37 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.3 m -92.42 95.38 9.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.433 0.635 . . . . 0.0 109.541 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.62 ' OD1' ' HG ' ' A' ' 6' ' ' LEU . 2.6 t-20 -87.85 90.6 8.44 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -54.46 -33.23 59.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 56.7 m -63.14 -21.79 66.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.548 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.62 ' HG ' ' OD1' ' A' ' 3' ' ' ASN . 44.1 mt -64.0 -34.86 78.97 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.572 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -97.05 98.28 9.93 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 59.52 34.81 22.6 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.295 1.038 . . . . 0.0 112.352 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 66.5 t30 57.76 37.04 27.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 0.0 109.627 -178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.18 84.32 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.6 20.68 65.65 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.1 m -113.67 135.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.092 0.472 . . . . 0.0 111.119 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 m -89.15 -10.38 47.4 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.3 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -108.95 -168.16 1.31 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.96 117.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.165 0.507 . . . . 0.0 111.313 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.4 t -84.18 139.18 32.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -125.8 92.06 3.52 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.754 0.788 . . . . 0.0 108.976 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -75.19 119.83 19.85 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.56 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.05 170.0 8.12 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -65.92 -43.56 87.74 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 118.677 0.671 . . . . 0.0 109.425 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.0 mm -103.55 110.11 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.81 -138.51 35.37 Favored Glycine 0 C--O 1.263 1.967 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.483 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -173.83 -176.74 1.26 Allowed 'General case' 0 C--O 1.242 0.705 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -156.91 169.96 23.6 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 171.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -131.29 149.48 52.54 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.52 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.1 mt -118.02 101.88 8.61 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.668 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 116.557 -0.292 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.036 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.3 m -72.79 97.54 2.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.585 ' ND2' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -92.87 79.59 4.67 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.125 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -53.89 -38.52 64.88 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.931 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 79.0 m -61.01 -21.77 63.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.585 HD23 ' ND2' ' A' ' 3' ' ' ASN . 2.9 mm? -81.86 -17.35 47.65 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.94 107.05 17.28 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.818 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 60.35 28.95 18.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.821 0.819 . . . . 0.0 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 6.3 t30 53.27 41.19 32.14 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.823 1.649 . . . . 0.0 110.801 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.43 0.8 80.03 Favored Glycine 0 CA--C 1.504 -0.639 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.346 177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.23 70.45 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 79.5 m -117.36 129.82 56.11 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -75.81 -29.15 58.59 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.863 0.363 . . . . 0.0 110.212 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.403 ' HB2' ' H ' ' A' ' 15' ' ' VAL . 3.0 p80 -85.19 -171.15 3.48 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.413 174.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.436 ' HB ' ' N ' ' A' ' 27' ' ' NH2 . 57.6 t -56.86 134.68 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 O-C-N 123.586 0.554 . . . . 0.0 111.838 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.6 t -113.41 148.72 35.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -130.75 102.98 6.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.83 118.96 19.18 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.549 0.69 . . . . 0.0 112.143 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 mt -103.36 166.55 10.36 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -67.37 -47.61 69.86 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 50.4 mm -99.12 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.93 -141.58 31.91 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.137 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -158.34 178.75 9.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.23 151.25 40.38 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 94.4 m -126.67 134.06 50.8 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -122.69 -103.82 0.38 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.274 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . 0.436 ' N ' ' HB ' ' A' ' 15' ' ' VAL . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 122.18 -0.325 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.753 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.1 t -97.06 115.32 27.26 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 122.183 0.992 . . . . 0.0 111.215 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.449 ' CG ' ' HG ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -105.72 104.52 14.25 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.056 -176.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -76.45 -37.56 56.76 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 123.597 0.759 . . . . 0.0 110.175 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 9' ' ' ASN . 74.8 m -58.4 -25.69 62.4 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 3' ' ' ASN . 63.6 mt -58.79 -39.25 80.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -111.41 125.32 53.75 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.748 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 63.35 19.46 11.7 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.572 1.149 . . . . 0.0 110.397 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 67.2 t30 58.4 33.05 22.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 114.14 -1.391 . . . . 0.0 109.156 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.31 6.61 61.87 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.343 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.93 78.78 Favored Glycine 0 N--CA 1.438 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.8 m -85.4 128.75 34.82 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.4 m -79.41 -21.94 44.93 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.512 0.672 . . . . 0.0 109.31 176.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -103.79 -167.48 1.38 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.928 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.8 t -57.75 131.24 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.1 t -98.02 137.6 36.58 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 24' ' ' GLU . 46.9 t30 -124.92 114.69 19.51 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -90.13 133.68 34.73 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.69 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 70.4 mt -115.93 166.25 12.19 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -55.41 -49.43 72.4 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.801 0.81 . . . . 0.0 109.368 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.88 131.41 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 54.79 -138.41 41.76 Favored Glycine 0 C--O 1.263 1.962 0 O-C-N 123.742 0.651 . . . . 0.0 112.671 -174.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -175.23 176.64 2.02 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 17' ' ' ASN . 22.3 pt-20 -144.39 138.52 27.82 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.983 0.42 . . . . 0.0 110.796 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.5 m -91.07 125.43 35.86 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.9 mt -113.8 -99.02 0.43 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.933 0 O-C-N 122.029 -0.419 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_